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Influence of habitual physical activity and acute exercise on lipid metabolism and insulin 
action 
by 
Rachael Katharine Nelson 
 
Although a physically active lifestyle is clearly an important contributor to long-term health and 
disease prevention, it remains unclear how much of these health benefits stem from the acute 
effects of the most recent session(s) of exercise, and how much can be attributed to physiologic 
adaptations accrued as a result of  habitual active.  Importantly, the time course for adaptations 
that occur in the early stages of adopting a habitually active lifestyle is not clearly understood.  
Therefore, my dissertation projects were designed to examine key metabolic adaptations that occur 
in response to a more physically active lifestyle in obese adults who are at risk for developing 
chronic metabolic diseases, including type 2 diabetes.  The major findings of my dissertation 
studies included: In STUDY#1, using data from the National Health and Nutrition Examination 
Survey (NHANES), we found that insulin sensitivity was significantly associated with the amount 
of time participants were engaged in physical activity behaviors (P=0.03), but not with their level 
of cardiorespiratory fitness. In STUDY #2, contrary to our hypothesis, Insulin Sensitivity Index 
(ISI) was significantly higher in a group of overweight adults who exercise regularly compared 
with a well-matched cohort of sedentary overweight adults, even though the regular exercisers 
abstained from exercise for 3 days.  In this study we also found that a single session of moderate-
intensity exercise was sufficient to increase ISI the day after exercise by nearly 25% in the 
previously sedentary overweight adults – but not in the regular exercisers, eliminating the 
difference in ISI between the groups that was evident at baseline.  In STUDY #3, although ISI was 
not improved in the hours after the first low-intensity exercise training session, after 2 weeks of 
training, post-exercise ISI was enhanced. We also discovered that a single session of exercise at 
50%VO2max (i.e., maximal oxygen uptake) for 40 min may be below a “threshold” for exercise 
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stimulus required to improve insulin sensitivity into the next day in obese adults. These studies 
provide important new information for optimizing the design of lifestyle interventions specifically 





Statement of the problem 
 
Two-thirds of the U.S. population is classified as overweight or obese (10).  Along with this 
alarming prevalence of obesity, there is also a very high incidence of obesity-related diseases, such 
as Type 2 Diabetes Mellitus (T2DM) (12, 13).  Over twenty-five million people in the United 
States have T2DM and there are nearly two million new cases reported each year (1).  In addition, 
it is estimated that 35% of U.S. adults have impaired fasting glucose, and are at increased risk for 
developing T2DM (1).  Unfortunately, T2DM contributes to other life threatening diseases 
including cardiovascular and renal disease.  In addition to the aforementioned health consequences, 
diabetes also contributes to the growing financial burden of health care costs at a rate well over 
$100 billion per year (1).  Therefore, the prevention and treatment of T2DM is a serious public 
health concern. 
 
Insulin resistance, defined as a subnormal response to a physiologic dose of insulin, is a major 
underlying symptom of T2DM, and it is also linked to the development of many other chronic 
diseases (9, 11).  Although losing only 5-10% of initial body weight can improve insulin resistance 
(15), even this very modest weight loss can be very difficult to both achieve and sustain (6).  
Importantly, increased physical activity can improve insulin resistance and impart important 
metabolic health benefits even without weight loss (8).  Because regular physical activity can also 
enhance maximal oxygen uptake (i.e., VO2max), a measure of cardiorespiratory fitness, some of the 
physiologic adaptations underlying changes in VO2max with exercise (e.g., mitochondrial 
biogenesis) have been credited with much of the exercise-induced improvements in metabolic 
health.  Consequently most current exercise recommendations are designed with the goal to 
improve “fitness”. However, mounting evidence indicates that many health benefits of exercise 
are not directly linked with improvements in VO2max (3, 8, 14), and it is quite possible that training 
programs designed to improve cardiorespiratory fitness may not be optimally designed for 
improving metabolic health.  This is particularly relevant because the more vigorous exercise 
2 
 
intensity required to improve VO2max has been associated with a greater incidence of injuries and 
participant discomfort, leading to poor exercise adherence (5).  
 
Epidemiological evidence clearly indicates that even a rather modest increase in regular physical 
activity behavior can profoundly reduce disease risk (2, 16).  However, this level of activity is 
often found to be insufficient to induce meaningful improvements in classic measures of 
cardiorespiratory fitness (e.g., maximal oxygen uptake; VO2max) (7).  Conversely, regularly 
performed vigorous exercise (which is known to induce the most robust improvements in VO2max) 
does not appear to result in further reduction in disease risk beyond that found with light and 
moderate intensity exercise (2, 16). Moreover, profound improvements in markers of 
cardiovascular and metabolic health, including insulin resistance are apparent in the several hours 
after a single session of exercise (4), which is clearly not enough of an exercise stimulus to evoke 
physiologic adaptations to improve aerobic capacity (i.e., VO2max).  Therefore, although a 
physically active lifestyle is clearly an important contributor to long-term health and disease 
prevention, it remains unclear how much of these health benefits stem from the acute effects of 
the most recent session(s) of exercise, and how much can be attributed to physiologic adaptations 
accrued as a result of exercising regularly.  Moreover, the time course for adaptations that occur 
in the early stages of adopting a habitually active lifestyle are not clearly understood.   
 
The studies outlined in my dissertation examined:  
 
1) the influence of habitual physical activity behavior and cardiorespiratory fitness on 
important risk factors for cardiovascular and metabolic disease [PROJECTS 1 and 2]. 
2) the effect of a single session of mild exercise on key factors associated with cardiovascular 
and metabolic disease in overweight and obese adults [PROJECTS 2 and 3]. 
3) progressive adaptations in insulin resistance, skeletal muscle lipid metabolism, and factors 
regulating these processes as previously sedentary obese adults begin a modest exercise 
program (i.e., after 1 day, 2 weeks, and 3 months of a low-intensity exercise training 




The overall objective of my dissertation projects was to examine key metabolic responses and 
adaptations to acute and habitual exercise on factors underlying cardiometabolic disease risk.  
These findings have important implications for designing lifestyle interventions specifically aimed 




1. Centers for Disease Control and Prevention. National diabetes fact sheet: national 
estimates and general information on diabetes and prediabetes in the United States, 
2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease 
Control and Prevention, 2011. Available from: 
http://www.cdc.gov/diabetes/pubs/factsheet11.htm. 
2. Borch KB, Braaten T, Lund E, and Weiderpass E, Physical activity and mortality 
among Norwegian women - the Norwegian Women and Cancer Study. Clin Epidemiol. 3: 
229-235 2011. 
3. Brestoff JR, Clippinger B, Spinella T, von Duvillard SP, Nindl BC, and Arciero PJ, 
An acute bout of endurance exercise but not sprint interval exercise enhances insulin 
sensitivity. Appl Physiol Nutr Metab. 34: 25-32 2009. 
4. Devlin JT and Horton ES, Effects of prior high-intensity exercise on glucose 
metabolism in normal and insulin-resistant men. Diabetes. 34: 973-979 1985. 
5. Dishman RK, Sallis JF, and Orenstein DR, The determinants of physical activity and 
exercise. Public Health Rep. 100: 158-171 1985. 
6. Douketis JD, Macie C, Thabane L, and Williamson DF, Systematic review of long-
term weight loss studies in obese adults: clinical significance and applicability to clinical 
practice. Int J Obes (Lond). 29: 1153-1167 2005. 
7. Duncan GE, Anton SD, Sydeman SJ, Newton RL, Jr., Corsica JA, Durning PE, 
Ketterson TU, Martin AD, Limacher MC, and Perri MG, Prescribing exercise at 
varied levels of intensity and frequency: a randomized trial. Arch Intern Med. 165: 2362-
2369 2005. 
8. Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, and Stacpoole PW, 
Exercise training, without weight loss, increases insulin sensitivity and postheparin 
plasma lipase activity in previously sedentary adults. Diabetes Care. 26: 557-562 2003. 
9. Faerch K, Bergman B, and Perreault L, Does Insulin Resistance Drive the Association 
between Hyperglycemia and Cardiovascular Risk? PLoS One. 7: e39260 2012. 
10. Flegal KM, Carroll MD, Ogden CL, and Curtin LR, Prevalence and trends in obesity 
among US adults, 1999-2008. JAMA. 303: 235-241 2010. 
11. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, and Levy D, Glycemic status 




12. Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, and D'Agostino RB, Sr., 
Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the 
Framingham Heart Study. Circulation. 113: 2914-2918 2006. 
13. Gordon-Larsen P, The NS, and Adair LS, Longitudinal trends in obesity in the United 
States from adolescence to the third decade of life. Obesity (Silver Spring). 18: 1801-
1804 2010. 
14. Heath GW, Gavin JR, 3rd, Hinderliter JM, Hagberg JM, Bloomfield SA, and 
Holloszy JO, Effects of exercise and lack of exercise on glucose tolerance and insulin 
sensitivity. J Appl Physiol. 55: 512-517 1983. 
15. Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, and Eckel 
RH, Clinical implications of obesity with specific focus on cardiovascular disease: a 
statement for professionals from the American Heart Association Council on Nutrition, 
Physical Activity, and Metabolism: endorsed by the American College of Cardiology 
Foundation. Circulation. 110: 2952-2967 2004. 
16. Wannamethee SG, Shaper AG, and Walker M, Changes in physical activity, 







Review of literature 
 
Obesity is now one of the leading public health concerns worldwide.  It is estimated that 1.5 billion 
adults around the world can be classified as overweight and another 500 million as obese (64).  
The United States has the highest obesity prevalence in the world, with two-thirds of the adult 
population classified as overweight or obese (26) and obesity rates are continuing to rise (29).  
Clearly, obesity has a profound impact on disease risk (48) and mortality (17).  Life expectancy is 
thought to be reduced by 4-10 years in overweight and obese compared with non-obese individuals 
(17). The increased mortality rates may be explained by increased incidence of cardiovascular 
disease (67), certain types of cancer (70), and type 2 diabetes mellitus (T2DM) (85) in overweight 
and obese individuals.  Without question, the very high and further accelerating prevalence of 
obesity and obesity-related health complications carries an enormous economic burden.  The direct 
costs of obesity on health care has reached nearly $147 billion annually in the U.S. (84).  Moreover, 
indirect costs associated with obesity (i.e. missed days of work, obesity related physician visits, 
etc.) are also high.  For example absenteeism alone is believed to cost an additional $4.3 billion 
annually.  Unfortunately, the projected cost of obesity related diseases such as T2DM in the U.S. 
is also high (84).  Estimates suggest that obesity-related chronic diseases will contribute to a rise 
in health care costs by a rate of $22-68 billion per year through 2030 (94).  Additionally, annual 
health care costs for individuals with diabetes is five times greater than that of individuals without 
diabetes and associated with $174 billion annually in direct and indirect health care costs (1).  
 
Although the increased disease risk associated with obesity is certainly caused by multiple factors, 
it appears that resistance to the physiologic actions of insulin (i.e., “insulin resistance”) underlies 
many obesity-related health complications including: T2DM, hypertension, dyslipidemia, as well 
as systemic and tissue inflammation (21, 27, 44, 64). Insulin resistance refers to the reduced ability 
of insulin to regulate nutrient metabolism in insulin-responsive tissues (e.g., skeletal muscle, liver, 
and adipose tissue).  More specifically, insulin resistance in skeletal muscle results in an impaired 
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ability of insulin to promote glucose uptake; in the liver, insulin resistance induces glucose 
overproduction; while insulin resistance in adipose tissue suppresses the normally potent anti-
lipolytic effects of insulin, resulting in an elevated lipolytic rate.  Therefore, obesity-induced 
insulin resistance in these tissues results in hyperglycemia, hyperinsulinemia, and an elevated 
systemic fatty acid availability, which are well known to be particularly detrimental to vascular 
and metabolic health (21, 27).  Hyperinsulinemia has also been found to increase blood pressure 
via vascular wall remodeling, vasoconstriction, and increased fluid retention (64).  Insulin 
resistance is thought to be a major contributor to the development of dyslipidemia (27), and the 
onset of insulin resistance typically precedes dyslipidemia in obese individuals (27).  Insulin 
resistant individuals have been reported to have 80% higher plasma triglyceride concentrations 
and 20% lower HDL-C concentrations than their insulin sensitive counterparts (44).  Collectively 
these findings suggest that interventions aimed at improving insulin resistance could have 
important implications for improving overall health.   
 
A physically active lifestyle can reduce disease risk 
For at least the better part of the last century accumulating epidemiological evidence supports the 
notion that a more physically active lifestyle is linked with lower morbidity and mortality rates 
(11), some of which may be attributed to reduced prevalence of insulin resistance, T2DM (40) as 
well as other chronic diseases (95).  The definition of a “physically active lifestyle” is very broad, 
and could range from regularly engaging in modest physical activity behaviors, like walking, to 
daily participation in very vigorous exercise training.  Current exercise guidelines recommend at 
least 2.5 hours of moderate-to-vigorous physical activity each week to prevent T2DM (2).  
Unfortunately, those more vigorous forms of physical activity are associated with greater 
participant discomfort and drop-out rates (20).  Light intensity physical activity however, appears 
to be the most prevalent form of physical activity (33, 50) and  is also associated with significant 
reductions in risk for developing T2DM (39).  In fact, compared with completely sedentary 
behavior, daily light physical activity such as walking is associated with a 34% reduction in the 
risk of developing T2DM (38) potentially resulting from better glucose tolerance and insulin 
sensitivity (34, 56).  For example, a cross-sectional study observed a similar inverse relationship 
between light physical activity and plasma glucose concentrations following a 2hr oral glucose 
tolerance test (34).  Further cross-sectional analyses have demonstrated similar increases in insulin 
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sensitivity in individuals who engage in more physical activity regardless of the intensity (56).  
Consequently, light intensity physical activity may be a very important therapeutic tool for 
improving glucose metabolism and ultimately reducing T2DM risk.  A better understanding of the 
underlying mechanisms that contribute to the improvement in insulin resistance when people begin 
to incorporate light/mild intensity physical activity into their daily lives could have important 
health implications for designing lifestyle interventions aimed at reducing T2DM risk.   
 
Current exercise guidelines emphasizing moderate-to-vigorous physical activity (2) in part stem 
from the understanding that regularly performed exercise at sufficiently high intensity can enhance 
cardiorespiratory fitness (e.g., maximal oxygen consumption (VO2max)), and higher 
cardiorespiratory fitness is associated with lower incidence of cardiovascular disease and T2DM 
even among overweight and obese individuals (51, 85).  Therefore, the subsequent improvement 
in VO2max resulting from regular physical activity/exercise is often credited for the exercise-
induced improvements in health (51, 85).  However, accumulating evidence suggests that many of 
the exercise-induced improvements in health may be independent of improved VO2max (19, 23).  
For example, several weeks of moderate intensity endurance training has been found to improve 
measures of insulin resistance and dyslipidemia in overweight and obese individuals in the absence 
of improved VO2max (23). Moreover, an overwhelming amount of evidence indicates that many of 
the effects of exercise on important health outcomes (e.g., insulin resistance, hypertension, 
dyslipidemia) are very transient (15, 35, 58).  Many studies demonstrate that the beneficial health 
effects of exercise training dissipate after only a few days (or less) without exercise (35), well 
before meaningful decrements in VO2max.  Additionally, a single session of exercise can greatly 
improve insulin resistance and reduce blood pressure in overweight and obese individuals at least 
into the next day (19, 24).  Yet one session of exercise is not enough of an exercise stimulus to 
enhance VO2max within the same time period.  Therefore, while it is clear that physical activity 
improves insulin resistance and metabolic health, the quantity or intensity of exercise required, 
and the underlying mechanisms responsible for this improvement are not completely understood.  
It remains uncertain how much of these health improvements are truly due to adaptations 
associated with the improvement in VO2max, compared with some other attributes of physical 
activity, per se.  Making this distinction becomes clinically relevant particularly when one 
considers that the vigorous activities/exercises required for robust improvements in VO2max are 
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associated with participant discomfort and injury, which are thought to contribute to poor 
adherence (20).  
 
Lipid oversupply and insulin resistance 
The rate of fatty acid mobilization from adipose tissue (lipolysis) is markedly higher in obese 
compared with lean adults (37), and this over-abundance of fatty acids in the systemic circulation 
is an important link between obesity and the development of insulin resistance (79).  Several 
studies have demonstrated that an elevation in plasma fatty acid availability via lipid and heparin 
infusion in lean, healthy adults results in profound insulin resistance within only 2-3 hours (22, 30, 
72).  Conversely, pharmacological suppression of lipolysis can improve insulin resistance in obese 
adults (69).  The exact mechanisms by which elevated systemic fatty acid availability leads to 
skeletal muscle lipid accumulation and insulin resistance are not completely understood.  Within 
skeletal muscle, in general fatty acids can either be oxidized in the mitochondria for energy 
production or stored in the form of intramyocellular triacylglycerols (IMTG) or lipid intermediates 
(i.e. diacylglycerol (DAG) and ceramide) (43).  While the accumulation of neutral lipids within 
IMTG stores is now largely understood to be inert (61), the accumulation of DAG and ceramides 
have been more directly linked with impaired insulin signaling (Figure 1) (41, 80, 86, 88, 91). 
DAG and ceramide are bioactive lipid species capable of activating as well as inhibiting cellular 
signaling pathways (31).  In the context of insulin resistance, DAG has been found to activate a 
novel protein kinase C (PKC) (41, 79), which has been implicated in serine phosphorylation of 
insulin receptor substrate-1 (IRS-1) (12) resulting in inhibition of the insulin signaling cascade, 
and the subsequent inhibition of translocation of the insulin-responsive glucose transporter 
(GLUT4) to the cell surface.  The insulin desensitizing effects of ceramides appear to occur just 
downstream of IRS-1 by reducing the phosphorylation of protein kinase B (PKB; also known as 
Akt), and by altering the translocation of Akt to the plasma membrane through activation of novel 
PKCs (36).  It has also been suggested that fatty acid-induced PKC activation may also increase 
other pro-inflammatory signaling pathways such as the Nuclear factor kappa-B (NF-κB) pathway, 
thereby reducing insulin sensitivity (41). Notably, compared with non-obese individuals, obese 
individuals show greater basal DAG accumulation and activation of pro-inflammatory pathways 





Figure 2-1. Influence of fatty acid intermediates (e.g., DAG, ceramide) on insulin signaling 
and glucose uptake.  Fatty acids enter the myocyte via facilitated diffusion, requiring transporter 
proteins such as CD36/FAT.  In general, the two major fates of fatty acids within the myocyte are 
to either be oxidized within the mitochondria for energy or to be esterified and stored as IMTG.  
Fatty acids that are not oxidized or stored as neutral lipids can accumulate as bioactive lipid 
intermediates including DAG and ceramide.  DAG can reduce insulin-stimulated glucose uptake 
by activating serine kinases (e.g., PKC), which serine phosphorylate IRS-1, thereby inhibiting 
insulin signaling and suppressing GLUT4 translocation to the cell membrane.  Ceramides can 
impair insulin signaling by acting (directly and indirectly) on Akt/PKB; via either 
dephosphorylation of Akt and/or interfering with Akt translocation to the plasma membrane. DAG 
and ceramides can also activate IKKβ, which phosphorylates IκBα/β resulting in the dissociation 
of IκB and NFκB (and IκB is subsequently degraded).  Upon dissociation with IκB, the liberated 
NFκB is now able to translocate to the nucleus where it up-regulates the transcription of key pro-
inflammatory cytokines (e.g., TNFa). DAG and ceramides can also activate JNK resulting in 
JNK’s migration to the nucleus where it also promotes the production of pro-inflammatory 
cytokines.  Abbreviations: GPAT, glycerol-3-phosphate acyltransferase; DGAT, diglyceride 
acyltransferase; IMTG, intramyocellular triacylglycerol; DAG, diacylglycerol; NF-κB, nuclear 
factor kappa-B; IκB, inhibitor of NF-κB; IKKβ, IκB kinase; JNK, c-jun N-terminal kinase, PKC, 
protein kinase C; IRS-1, insulin receptor substrate-1; PI3K, Phosphatidylinositol 3-kinase; 
Akt/PKB, protein kinase B; GLUT4, glucose transporter type 4. 
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Exercise-mediated improvements in insulin resistance may be due in part to alterations in the 
metabolism of fatty acids within muscle, perhaps leading to a reduction in the accumulation of the 
“damaging” lipid intermediates.  Our lab has demonstrated that an acute session of exercise 
protected against insulin resistance during a lipid infusion that was administered in the several 
hours after exercise (76). This protection against lipid-induced insulin resistance was accompanied 
by an increase in the accumulation of IMTG, and a reduction in DAG and ceramides, suggesting 
that the exercise session facilitated the partitioning of fatty acids that entered the muscle toward 
storage as neutral lipids in IMTG, rather than the other lipid intermediates.  Our finding that the 
protein abundance of key enzymes in the IMTG synthesis pathway (i.e., glycerol-3-phosphate 
acyltransferase (GPAT) and diglyceride acyltransferase (DGAT)) were up regulated the morning 
after this single session of exercise helped to support this hypothesis (76).  In conjunction with the 
reduced accumulation in muscle DAG and ceramide, we also found reduced 
phosphorylation/activation of JNK and increased abundance of IκB-α and IκB-β (76). Collectively 
these findings suggest that exercise may increase insulin sensitivity by acutely repartitioning fatty 
acids away from formation/accumulation of DAG and ceramides, and reduce markers of cellular 
inflammatory-stress. 
 
It is important to note that the study described above (76) was performed in lean adults undergoing 
an overnight lipid/heparin infusion in attempt to mimic the elevated fatty acid availability in 
obesity.  However, the responses to exercise in obese subjects, who are chronically exposed to 
elevated fatty acid availability, may be rather different. For example, we recently found that a 
single session of low intensity exercise (at 50% VO2max) also improved insulin sensitivity the 
next day in obese individuals, but this improvement in insulin sensitivity was not accompanied by 
measurable reductions in DAG concentration (62).  It is possible that the relatively large muscle 
lipid pools commonly found in obesity may make it very challenging to detect rather subtle (but 
perhaps physiologically meaningful) changes in muscle DAG abundance.  But we also must 
acknowledge that the effects of exercise on lipid partitioning in obesity may differ from the effects 
we found in lean subjects who were acutely exposed to an overnight lipid infusion.    
 
As described above, the insulin sensitizing effects of exercise training (and the subsequent 
improvement in aerobic capacity) are controversial, but much of the effects of exercise on insulin 
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sensitivity appear to stem from the most recent session(s) of exercise (58).  In the context of 
exercise training and lipid-induced insulin resistance, there has been considerable debate about the 
role of increased oxidative capacity on the accumulation of intramyocellular lipids (66, 75, 77, 
89).  A greater accumulation of these lipids within muscle of obese individuals (5, 7) suggests a 
mismatch between fatty acid uptake and oxidation in skeletal muscle.  Indeed, obese individuals 
are often found to have lower oxidative capacity than their non-obese counterparts (7, 47).  
Therefore, it has been proposed that the accumulation of lipid within skeletal muscle may be a 
consequence of lower oxidative capacity (10).  However, increased oxidative capacity alone is not 
sufficient to improve skeletal muscle insulin resistance (75, 81).  Therefore, although the 
contribution of a low oxidative capacity on muscle lipid accumulation and insulin resistance 
remains to be resolved, the negative impact of a high rate of fatty acid flux into the muscle is 
generally well accepted (6, 72, 79). 
 
Influence of adipose tissue inflammation on insulin resistance 
Obesity has been characterized as state of low-grade systemic inflammation that has been linked 
to the development of skeletal muscle insulin resistance (65, 78).  Once thought of as simply a 
storage depot for excess nutrients, we now know that adipose tissue can also act as an important 
paracrine and endocrine organ, secreting peptides known to influence insulin resistance (42, 65, 
78).  Although the regulation and release of pro-inflammatory peptides (i.e. cytokines) from 
adipose tissue is not completely understood, much of the adipose-derived cytokine production in 
obesity may actually be produced in macrophages that infiltrate adipose tissue (42). In general 
there are two types of macrophages classically referred to as “M1” and “M2” macrophage, 
associated with pro- and anti-inflammatory protein secretion respectively.  Compared with non-
obese individuals, total macrophage abundance is higher in obesity (65) and there also appears to 
be a shift toward more M1 macrophage with obesity (52).  Increased macrophage accumulation 
with adipose tissue may be at least partially explained by increased systemic availability of fatty 
acids that has been previously shown to increase adipose tissue macrophage accumulation (49).  
Additionally, hypertrophy of adipocytes, as seen in obesity, induces secretion of pro-inflammatory 
cytokines including tumor necrosis factor-alpha (TNFα), interleukin-1 beta (IL-1β), interleukin-6 
(IL-6), and monocyte chemoattractant protein-1 (MCP-1) (Figure 2-2) (42).  Consequently, 
cytokines released within adipose tissue can influence inflammatory signaling in adipose tissue 
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and skeletal muscle through systemic circulation.  Within adipose tissue, both TNF-α and IL-1β 
have been found to promote lipolysis, resulting in liberation of both saturated and unsaturated fatty 
acids (28, 74).  In turn saturated fatty acids have been shown to activate Toll Like Receptor-4 
(TLR-4) resulting in the translocation of NF-κB to the cell nucleus where it acts as a nuclear 
transcription factor in the production of more pro-inflammatory proteins (i.e., TNF-α, IL-1β, IL-
6, and MCP-1) from adipose tissue into systemic circulation.  Furthermore, the cytokine MCP-1 
specifically attracts more macrophage to adipose tissue (97).  In addition, with increasing 
adipocyte cell volume with weight gain and obesity there is a reduction in adipose tissue blood 
flow (8) which can induce hypoxia (97).  Hypoxia can activate both transcription factors HIF1-α 
and NF-κB, which have been linked with increasing M1 macrophage infiltration and pro-












Figure 2-2. Adipose tissue inflammatory pathways leading to increased systemic circulation 
of pro-inflammatory cytokines.  As adipocytes hypertrophy with weight gain and obesity, M1 
macrophages are preferentially recruited to adipose tissue, and the ratio of M1-to-M2 macrophage 
increases.  M1 macrophages produce pro-inflammatory cytokines, while M2 macrophage are 
considered anti-inflammatory.  In addition, with increasing adipocyte cell volume, capillary 
density diminishes, which can induce hypoxia.  Hypoxia activates transcription factor HIF1-α, 
which has been linked with increasing M1 macrophage infiltration and augmenting inflammation 
in adipose tissue. Hypoxia can also induce translocation of NF-κB and the secretion of pro-
inflammatory cytokines as previously described.  Abbreviations: HIF1-α, hypoxia-inducible 
factor-1, alpha; M1, pro-inflammatory macrophage; M2, anti-inflammatory macrophage; TNF-α, 
tumor necrosis factor-1 alpha; IL-1β, interleukin-1 beta; IL-6, interleukin-6; MCP-1, monocyte 




Systemic pro-inflammatory cytokines (i.e. TNF-α, IL-6, and MCP-1) are positively associated 
with measures of insulin resistance (3, 46, 53), but how these cytokines influence insulin resistance 
within skeletal muscle is not completely understood.  Similar to the inflammatory response within 
adipose tissue, available evidence suggests that pro-inflammatory cytokines can directly influence 
skeletal muscle insulin resistance through inhibition of the insulin signaling cascade or indirectly 
through activation of pro-inflammatory pathways that may circulate back and inhibit insulin 
signaling (Figure 3) (96).  In fact, it has been found that macrophage accumulation is also elevated 
in skeletal muscle of obese individuals, and their abundance is inversely associated with insulin 
sensitivity (92).  It is also known that TLR-4 expression is elevated in obese insulin resistance 
individuals (71)  In vitro studies using human derived myocytes have shown that physiological 
concentrations of IL-1β and IL-6 are sufficient to inhibit insulin signaling at the level of Akt/PKB 
serine phosphorylation and MCP-1 can reduce insulin stimulated glucose uptake (82).  Importantly 
many pro-inflammatory cytokines (i.e., TNF-α, IL-1β, IL-6, and MCP-1) are known to be 
produced endogenously within skeletal muscle (13).  This makes it difficult to determine the 
influence of adipose tissue and skeletal muscle derived pro-inflammatory cytokines on insulin 
signaling.  This is especially so because in vivo models of inflammation and insulin signaling or 
glucose uptake have focused primarily on either adipose tissue or skeletal muscle (45, 53, 71, 92).  
Therefore, assessing both adipose tissue and skeletal muscle inflammation in obese individuals 
may contribute to our understanding in the relationship between inflammation and skeletal muscle 












Figure 2-3. Influence of pro-inflammatory cytokines on skeletal muscle insulin resistance.  
Pro-inflammatory cytokines (e.g., TNFα, IL-1β) can inhibit insulin stimulated glucose uptake 
within skeletal muscle through activation of IKKβ and JNK resulting in serine phosphorylation of 
IRS-1, thereby inhibiting insulin signaling and suppress GLUT4 translocation to the cell 
membrane.  These cytokines can also work more indirectly by facilitating the ability of NF-κB and 
JNK to migrate the nucleus, which can increase the transcription of additional inflammatory 
cytokines.  These cytokines may then exit the cell and interact with cell surface membrane 
receptors (in an autocrine and paracrine manner), further perpetuating the pro-inflammatory cycle 
and the inhibition of the insulin signaling.  Abbreviations: NF-κB, nuclear factor kappa-B; IκB, 
inhibitor of NF-κB; IKKβ, IκB kinase; JNK, c-jun N-terminal kinase, PKC, protein kinase C; IRS-
1, insulin receptor substrate-1; PI3K, Phosphatidylinositol 3-kinase; Akt/PKB, protein kinase B; 




Influence of acute and habitual physical activity on adipose tissue, systemic, and skeletal 
muscle inflammation 
The effects of exercise/physical activity on the abundance of pro-inflammatory cytokines in 
adipose tissue, systemic circulation, and skeletal muscle of obese individuals remain unresolved.  
In adipose tissue, hypoxia has been proposed to be a major mediator of inflammation through 
activation of the NFκB pathway (97) and by reducing efflux of macrophage from adipocytes (90).  
A potent stimulator of angiogenesis, exercise may reduce pro-inflammatory signaling in adipose 
tissue through enhanced blood flow.  Hypoxia inducible-factor 1 (HIF-1) is a transcription factor 
and master regulator of genes involved in oxygen homeostasis inducing expression of hypoxia 
inducible-factor 1α (HIF-1α) leading to the transcription of vascular endothelial growth factor 
(VEGF) and ultimately increased angiogenesis (83).  Obese individuals show reduced adipose 
tissue blood flow (57) and increased expression of HIF-1α (14).  At least in rodent models exercise 
training does appear to increase capillary density of adipose tissue (32) and reduce M1 macrophage 
as well as TLR-4 expression (45).  However, to our knowledge markers of hypoxia and 
vascularization have not been examined in response to exercise training in obese individuals.  If 
exercise training can influence the inflammatory profile within adipose tissue it does not appear to 
modulate the systemic pro-inflammatory state of obese individuals who demonstrate no change in 
IL-6, TNF-α, or MCP-1 with 12 weeks of exercise training when measured 24-48 hrs after 
participants last exercise training session (16).  A better understanding of the inflammatory 
response to acute and habitual physical activity within adipose tissue and in the systemic 
circulation of obese individuals could have important implications for designing lifestyle 
interventions aimed at reducing disease risk associated with chronic inflammation.   
 
Much less is known about the inflammatory state of muscle in response to physical 
activity/exercise training in overweight and obese humans.  Macrophage accumulation is higher 
in skeletal muscle of obese individuals (92) and capable of endogenous production of pro-
inflammatory cytokines (96).  Acutely, exercise stimulates the production and secretion of IL-6 
from skeletal muscle (25).  However, the release of these cytokines peaks at the end of exercise 
and is relatively low in the basal state of lean individuals (25).  It is not clear whether macrophages 
are the source of IL-6 production in skeletal muscle.  Monocytes are precursor cells for 
macrophage and also classically characterized as pro- and anti-inflammatory (68).  Overweight 
and obese individuals show greater markers of pro-inflammatory monocytes (87).  While exercise 
18 
 
training has been shown to reduce the percentage and concentration of pro-inflammatory 
monocytes (87), expression of macrophage and pro-inflammatory cytokines within skeletal muscle 
remains unchanged (16).  Therefore, it is not clear how acute and habitual physical activity 
influence markers of inflammation in skeletal muscle.  Determining the inflammatory state of 
adipose tissue, systemic circulation, as well as skeletal muscle could provide a more complete 
understanding of how exercise/physical activity contributes to improved cardiovascular and 






Figure 2-4. Potential targets for assessing adipose tissue, systemic and skeletal muscle 
inflammation in response to acute exercise and habitual physical activity.  My dissertation 
projects were designed to examine the effects of acute exercise and habitual physical activity on 
insulin sensitivity, and markers for inflammatory pathway activation that may affect insulin action 
in muscle.  In addition, I also explored the effects of acute exercise and habitual physical activity 
(without weight loss) on pro-inflammatory cytokine profile within adipose tissue and systemic 




Measure of insulin resistance – strengths and limitations 
Insulin resistance and insulin sensitivity are major outcomes for the projects of my dissertation.  
Many different methods have been used, and validated, to assess insulin resistance in humans.  
These methods range from rather crude assessments based on fasting plasma glucose and insulin 
concentrations e.g., Homeostatic Model Assessment of Insulin Resistance [HOMA-IR], to more 
involved/sophisticated methods requiring glucose and insulin infusion (e.g., hyperinsulinemic-
euglycemic clamp).  Although HOMA-IR has been reported to correspond well with insulin 
resistance measured using the “gold-standard” clamp procedure (93), there are very important 
limitations of using HOMA-IR in part because this measure only involves fasting glucose and 
insulin rather than changes in glucose metabolism in response to an increase in insulin.  However, 
HOMA-IR has been acknowledged to be a useful tool for assessing insulin sensitivity in large-
scale epidemiological studies (54, 93) such as the NHANES databases used in PROJECT #1 of 
my dissertation.             
 
A more involved method of estimating insulin resistance includes measurements of plasma glucose 
and insulin concentration during an oral glucose tolerance test (OGTT).   Calculations estimating 
whole-body, muscle and hepatic insulin sensitivity have been derived from the OGTT and compare 
reasonably well with measures acquired with the hyperinsulinemic-euglycemic clamp (4, 55).  The 
product of glucose and insulin area under the curve (AUC) within the first 30 minutes of the OGTT 
has been used as a measure of hepatic insulin resistance (4).  In healthy individuals the rise in 
plasma glucose and insulin within the first 30 minutes of the OGTT should be sufficient to suppress 
endogenous glucose production from the liver.  Therefore, elevated plasma and insulin 
concentrations within that time frame reflect the inability of insulin to suppress endogenous 
production of glucose from the liver.   
 
Hepatic Insulin Sensitivity Index = [Glucose AUC0-30] x [Insulin AUC0-30]  
 
As noted, this method of estimating hepatic insulin resistance has been shown to be significantly 
correlated with more direct measures of hepatic insulin resistance (4).  Likewise, assuming hepatic 
glucose production is nearly completely suppressed 30 minutes into the OGTT, the reduction in 
plasma glucose concentration would reflect peripheral glucose uptake.  Therefore, the decline in 
20 
 
glucose concentration from peak to nadir during the OGTT, divided by the average insulin 
concentration during this timeframe has been used as an indicator of peripheral insulin resistance 
and is also significantly associated with more sensitive measures of peripheral insulin sensitivity 
(4).   
 





In addition to these tissue-specific indices of insulin sensitivity, the Matsuda Composite Index of 
Insulin Sensitivity (ISI) provides a measure of whole body insulin sensitivity as a product of fasting 
plasma glucose and insulin concentration and average plasma glucose and insulin concentration in 
response to a glucose load (55).  This calculation is derived from the assumption that fasting 
glucose concentration is indicative of endogenous glucose production from the liver as a function 
of insulin concentration and the average plasma glucose and insulin concentration during the 
OGTT reflects both the suppression of hepatic glucose production and disposal of glucose in 
peripheral tissues.   
 
𝑀𝑎𝑡𝑠𝑢𝑑𝑎 𝐶𝑜𝑚𝑝𝑜𝑠𝑖𝑡𝑒 𝐼𝑛𝑑𝑒𝑥
= 10,000/ √[(fasting insulin x fasting glucose) x (2h glucose x 2h insulin) 
 
Similarly, ISI is also significantly correlated to the hyperinsulinemic-euglycemic clamp method of 
measuring insulin resistance (55).  Unlike both HOMA-IR and the hyperinsulinemic-euglycemic 
clamp method of determining insulin resistance, ISI is a dynamic measure of insulin resistance in 
response to a glucose load potentially reflecting a normal meal for an individual.  Therefore, the 
glucose and insulin response to a glucose load similar to a “meal” may have very important clinical 
implications in populations at increased risk for T2DM.  Also the OGTT has been repeatedly found 
to respond fairly quickly (within a day) to activity and inactivity (35, 73) suggesting that it would 
be an appropriate measure of insulin resistance for PROJECT #2 of my dissertation examining the 




The most sensitive measure of insulin resistance, and currently the “gold standard” for determining 
insulin resistance, is the hyperinsulinemic-euglycemic clamp method (60).  The hyperinsulinemic-
euglycemic clamp method involves two intravenous catheters in contra-lateral arms for a constant 
infusion of insulin and variable infusion of glucose  as well as frequent arterialized blood draws at 
a rate of one every five minutes (18, 60).  Additionally a stable isotope tracer infusion of glucose 
can also be used to distinguish between hepatic and peripheral insulin resistance (60).  Because of 
the level of involvement of the clamp procedure, it is not ideal for large epidemiological or clinical 
investigations (60).  However, there are two important advantages to the hyperinsulinemic-
euglycemic clamp method including its relatively high degree of reproducibility and low 
variability (60).  This makes the hyperinsulinemic-euglycemic clamp method ideal for smaller 
experimental investigations examining subtle yet potentially meaningful changes in insulin 
resistance similar to the study proposed in PROJECT #3 of my dissertation examining the 
progressive adaptations associated with adapting a fairly modest exercise training program in 
obese adults.   
 
Summary of review of literature 
The overall objective of my dissertation projects was to thoroughly examine key metabolic 
adaptations that are consistent with a habitually active lifestyle.  These findings will have important 
implications for designing lifestyle interventions specifically aimed at enhancing metabolic health 
in overweight individuals.  Although increased physical activity is clearly known to improve 
metabolic health, the optimal amount of exercise required, and the underlying mechanisms 
contributing to this improvement are not completely understood.  Most current exercise 
recommendations are designed with the goal to improve cardiorespiratory fitness (e.g. maximal 
oxygen uptake (VO2max)) (2). However, mounting evidence suggests many health benefits of 
exercise are largely independent of improvements in VO2max, suggesting a training program 
designed to improve “fitness” may not be optimal for improving metabolic health.  This is 
particularly relevant because the higher intensity exercise required to improve VO2max often leads 
to poor exercise adherence (20). Additionally, many of the metabolic health benefits of exercise 
actually stem from the most recent exercise session(s), rather than from adaptations to weeks, 
months, and even years of exercise training (19, 24). Insulin resistance is also linked to the 
development of many other chronic diseases, and it is a primary outcome measure of my 
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dissertation studies (21, 27, 44, 63). Despite clear evidence that insulin resistance is greatly 
improved after a vigorous session of exercise (i.e., 24-48 hrs after exercise – but mostly dissipates 
after that), the effects of cumulative sessions of a more modest exercise/physical activity program 
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Daily physical activity predicts degree of insulin resistance: a cross-sectional observational 
study using the 2003–2004 National Health and Nutrition Examination Survey 
 
Abstract 
This study examined the independent association of objectively measured physical activity on 
insulin resistance while controlling for confounding variables including: cardiorespiratory fitness, 
adiposity, sex, age, and smoking status.  Data were obtained from National Health and Nutrition 
Examination Survey 2003-2004, a cross-sectional observational study conducted by the National 
Center for Health Statistics of the Centers for Disease Control that uses a stratified, multistage 
probability design to obtain a nationally representative sample of the U.S. population. The analysis 
included 402 healthy U.S. adults with valid accelerometer, cardiorespiratory fitness, and fasting 
plasma glucose and insulin concentrations. After controlling for relevant confounding variables 
we performed a multiple linear regression to predict homeostatic model of insulin resistance 
(HOMA-IR) based on average daily minutes of moderate-to-vigorous physical activity (MVPA).  
In our bivariate models, MVPA, cardiorespiratory fitness and body fat percentage were all 
significantly correlated with log HOMA-IR. In the complete model including MVPA and relevant 
confounding variables, there were strong and significant associations between MVPA and log 
HOMA-IR (β= -0.1607, P=0.004). In contrast the association between cardiorespiratory fitness 
and log HOMA-IR was not significant.  In conclusion, when using an objective measure of 
physical activity the amount of time engaged in daily physical activity was associated with lower 
insulin resistance, whereas higher cardiorespiratory fitness was not. These results suggest that the 
amount of time engaged in moderate-to-vigorousphysical activity may be an important 
determinant for improving glucose metabolism.  
 




The incidence of obesity-related diseases, such as type 2 diabetes is increasing in parallel with the 
alarming rise in the prevalence of obesity (16). Lifestyle programs involving weight loss and 
exercise are often found to improve insulin resistance (IR) in individuals with diabetes, and also 
to prevent or delay the onset of diabetes in those at risk of developing the disease (2). Although 
weight loss can markedly improve IR, exercise can also improve IR even in the absence of weight 
loss. Additionally, although improved cardiovascular “fitness” in overweight and obese 
individuals is linked with a reduced incidence of diabetes, exercise can also improve IR without 
enhancing cardiovascular fitness (11). For example, a single session of exercise can have a 
profound improvement on IR that can persist for several hours and even days (7, 25). Collectively 
this evidence suggests that exercise, per se, provides a potent stimulus for improving IR. Therefore, 
promoting a lifestyle change to increase regular physical activity (PA), even if it is not sufficient 
to induce weight loss or improve cardiovascular fitness, may be a viable and realistic intervention 
option aimed at reducing diabetes risk. 
 
“PA” is broadly defined to include any bodily movement produced by skeletal muscle that 
increases energy expenditure (1). Until recently it has been difficult to quantify ambulatory PA in 
free-living individuals. Large cohort studies have traditionally used self-reported surveys to 
measure PA, contributing to errors in determining the intensity and duration of PA (12, 23). 
However, objectively measured PA has been shown to be a better predictor of metabolic health 
than self-reported PA (5). Accelerometers, currently the gold standard for objectively measuring 
PA in a free-living population (26), were incorporated into the National Health and Nutrition 
Examination Survey (NHANES) 2003-2004 survey, a nationally representative sample of 
residence in the U.S. Analysis of fasting blood samples (including plasma concentrations of insulin 
and glucose), and other variables known to influence IR (i.e. cardiorespiratory fitness, and total 
body adiposity) were also determined for a subset of healthy participants in this NHANES cohort. 
The objective measurement of these constructs in a large representative cohort of U.S. adults 
allows more precise estimates than in previous studies along with an opportunity to access lower 
intensity PA that is difficult to quantify by self-report. Therefore, the aim of our study was to 
examine the independent association of objectively measured PA on IR while controlling for 





NHANES is a cross-sectional observational study conducted by the National Center for Health 
Statistics of the Centers for Disease Control and Prevention that uses a stratified, multistage 
probability design to obtain a nationally representative sample of the U.S. population. The survey 
population included randomly selected households within clusters of neighborhoods. Of the 12,761 
individuals selected during the 2003-2004 survey, 10,122 individuals agreed to participate. The 
NHANES 2003-2004 survey included an interview, physical examination and laboratory testing 
conducted by trained staff. Only non-pregnant adults aged 18-49 without a history of diabetes (or 
taking medication to treat diabetes), cardiovascular or renal disease, stroke or emphysema were 
included in this analysis. Because participants were scheduled for either a morning blood draw 
after a 9-hour fast or an afternoon blood draw after a 6-hour fast, a fasting questionnaire was used 
to determine whether or not participants met the fasting requirements. Therefore, fasting glucose 
and insulin used to calculate the primary outcome of homeostatic model of IR (HOMA-IR) were 
only available on approximately half of the NHANES participants who were classified as fasted. 
Also, only participants who successfully completed submaximal VO2max fitness test in order to 
determine cardiorespiratory fitness were included in this analysis (Figure 3-1).     
 
Assessment of insulin resistance 
Blood samples were obtained by trained medical personnel in mobile examination centers after a 
6- or 9-hour fast. Samples were centrifuged; the plasma from each sample was placed into storage 
test tubes, shipped to the University of Missouri-Columbia (Columbia, Missouri), and stored at -
70˚ until analysis. Plasma glucose concentration was determined by hexokinase enzyme method. 
Plasma insulin concentrations were measured with Tosoh AIA-PACK IRI (Toyama, Japan) two-
site immunoenzymometric assay. Individuals with fasting insulin concentrations < 2 µIU/mL or > 
100 µIU/mL (n = 34) were considered outliers and were excluded from the analysis. HOMA-IR 
(the product of fasting plasma glucose and insulin concentrations divided by 22.5 






Assessment of habitual physical activity 
PA was monitored by an Actigraph AM-7164 accelerometer (formerly the CSA/MTI AM-7164, 
manufactured by ActiGraph of Ft. Walton Beach, FL), which is a pager-sized device powered by 
a small lithium battery and attached to an elasticized belt worn on the right hip (33). The 
accelerometer measured the duration and intensity of PA by capturing the magnitude of 
acceleration (intensity) and summing the magnitudes (intensity counts) within a specified time 
interval (epoch). A one-minute epoch was used by NHANES (17). Participants were asked to wear 
the device for seven consecutive days while they were awake and to remove it while swimming or 
bathing. Monitors were returned by express mail to NHANES, where data were downloaded and 
the device was checked to determine whether it was still within manufacturer’s calibration 
specifications. NHANES used standardized data quality procedures to assess validity and 
reliability of Actigraph ACC data (17). Our analysis included PA data from participants who wore 
the accelerometer for at least 600 minutes on four or more days of the week. Any block of time 
greater than or equal to 60 minutes where the activity count was equal to zero was considered time 
when the monitor was not worn. Each minute of accelerometer data was coded based on the 
recorded activity counts for that minute.  Minutes with ≥1952 activity counts were coded as 
moderate-to-vigorous intensity PA (MVPA) and  ≥260 and <1952 activity counts were coded as 
light PA (24). We summed the number of minutes at these intensities over the entire day. This 
activity did not have to represent clearly defined sessions of exercise or be sequential and were 
thus accumulated throughout the day. Minutes of activity were divided by 30 to reduce the risk of 
rounding error in regression betas due to the fine scale of activity minutes. This calculation yields 
a measure of PA in which each unit represents approximately 30 minutes of PA per day. Changes 
to the units do not affect the associations described by our analysis.   
 
Assessment of cardiorespiratory fitness 
A multiple-stage submaximal treadmill exercise test was employed to estimate maximal oxygen 
consumption (VO2max), which was used as the marker for cardiorespiratory fitness. Per NHANES 
protocol, inclusion criteria for exercise testing were based on medical conditions, medication and 
physical limitations determined during household interviews, and limited to adults 18-49 years 
who did not have any known cardiac conditions. A detailed list of inclusion criteria and 
submaximal exercise testing procedures can be found elsewhere (4). Briefly, the exercise test 
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included a two-minute warm-up on the treadmill, two separate three-minute submaximal exercise 
stages and a two-minute cool-down. Heart rate associated with known workloads at the end of 
each stage were used to estimate VO2max, as previously described (4). Grade and speed for each 
stage were selected based on age, sex, body mass, and self reported PA. Heart rate was monitored 
throughout the test by four electrodes attached to the participant’s thorax and abdomen. Individuals 
with non-physiological estimates of VO2max (> 100 ml/kg/min, n=3) were excluded from the 
analysis.    
 
Anthropometric measures 
A wall-mounted stadiometer and a digital floor scale were used to measure height and weight, 
respectively, and calibrated as previously described (31). Body fat percentage was determined by 
dual-energy X-ray absorptiometry (DEXA) using Hologic QDR-4500A fan-beam densitometer 
(Hologic, Inc., Bedford, Massachusetts) (3). The DEXA was performed by a certified radiology 
technologist, and the densitometer was calibrated daily with a Hologic Anthropomorphic Spine 
Phantom as directed by the manufacturer.   
 
Smoking status 
Smoking status was determined by measuring plasma serum levels of cotinine, which is a major 




Age at the time of the survey was calculated from the participant’s self-reported date of birth. 
Participants were classified into 1 of 4 categories for race/ethnicity based on self-reported 
background: Non-Hispanic white, Non-Hispanic black, Mexican American, or other.    
 
Statistical analysis 
Descriptive statistics include means, standard deviations, and range for continuous variables 
(glucose, insulin, HOMA-IR, PA, VO2max, percent body fat, and age). Frequencies were 
calculated for categorical variables (i.e. sex and race/ethnicity). Because HOMA-IR was not 
normally distributed, we used log HOMA-IR as the primary outcome variable in our regressions. 
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Multiple linear regressions were performed with log HOMA-IR as the dependent variable.  
HOMA-IR was transformed using the log function to correct for the skewed distribution.  Minutes 
of MVPA and VO2max were the primary predictor variables. Appropriate confounding variables 
including: adiposity, sex, and age were also included in our complete model. Model parameters 
were also stratified by sex. Race/ethnicity and smoking status did not significantly impact model 
estimates and was not included in any reported models. Adjusted r-squared values were calculated 
during the addition of confounding variables to our complete model. We also examined variance 
inflation factors to determine multicollinearity in our complete model.   
 
Predicted mean values of HOMA-IR with confidence intervals were calculated for various levels 
of PA using the complete multiple linear regression including PA, cardiorespiratory fitness, 
percent body fat, age, and sex as independent variables.     
 
All analysis took into consideration NHANES complex survey design including: weighting, 
stratification, and clustering. Sample weights for the NHANES 2003-2004 fasting sample were 
used. For all analysis, significance was set at <0.05. Statistical analysis was performed using Stata 




Of the 10,122 participants in the 2003-2004 NHANES sample, 883 were healthy, non-pregnant 
adults between the ages of 18-49 who were scheduled for a morning fasting blood draw. Of those 
883 participants, 402 had valid data for HOMA-IR calculations, estimated VO2max, and PA 
(Figure 3-1). Categorical and continuous summary statistics of the final sample are presented in 
Table 3-1.  The 481 individuals who were excluded from the analysis were slightly older, heavier 
and more likely to be non-white than the 402 with complete data (Table 3-1).   
 
Regression models 
Parameter estimates for the four different regression models were presented in Table 3-2. We did 
observe a weak but significant relationship between cardiorespiratory fitness and physical activity 
(r2=0.1065, P<0.01; Figure 3-2).  Importantly variables in our complete model did not demonstrate 
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multicollinearity with an average variance inflation factor of 1.55 (range: 1.05-2.19). In bivariate 
models, MVPA and cardiorespiratory fitness were all significantly correlated with log HOMA-IR 
with higher levels of MVPA (β=-0.224, P=0.024) and cardiorespiratory fitness (β=-0.019, 
P=0.003) predicting lower log HOMA-IRs. However, in our complete model (Model 4), including 
predicting and confounding variables (cardiovascular fitness, body fat percentage, age and sex), 
the association between cardiorespiratory fitness and log HOMA-IR became non-significant while 
MVPA remained significantly correlated with log HOMA-IR. When stratified by sex, our analysis 
did not show any evidence of moderation by sex on the association between MVPA and log 
HOMA-IR (data not shown).   
 
Light physical activity 
We also examined minutes of light PA in our analysis. Although not statistically significant, there 
was a trend for an association between LPA and log HOMA-IR in our bivariate model (β=0.0288, 
P=0.099) and for LPA to predict log HOMA-IR when included in a more complete model with 
confounding variables (β=-0.0214, P=0.093). Importantly, when both LPA & MVPA were 
modeled with confounding variables, MVPA remained a significant predictor of log HOMA-IR 
(β=0.1457, P=0.035) while LPA (β=-0.0154, P=0.184) and cardiovascular fitness (β=0.0015, 
P=0.760) did not. 
 
Prediction of HOMA-IR based on Model 4.  
The predicted HOMA-IR means with confidence intervals for a range of MVPA levels are 
presented in Table 3-3. Assuming that the association found in Model 4 is causal, if the average 
individual in our model (based on means presented in Table 1 for predicting and confounding 
variables) who initially does not engage in any MVPA and subsequently increases his/her PA to 
30 minutes of MVPA a day can decrease their HOMA-IR by 0.26 which is an 13% reduction in 
HOMA-IR.   
 
Additional correlational analyses 
Please note that in the process of responding to reviewers’ comments for this submitted manuscript 
(which is now accepted for publication in the International Journal of Behavioral Nutrition and 
Physical Activity), it was requested that we remove some comparisons from the accepted 
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manuscript that I had included in my original dissertation proposal.  These additional comparisons 
were to examine the independent association between physical activity and mean arterial pressure 
(MAP), total cholesterol (Total-C), and C-reactive protein as well as the independent association 




Although increased PA is known to improve IR, the mechanisms underlying this improvement are 
not completely understood. More specifically, it is difficult to distinguish the metabolic benefits 
of PA, per se, from the improvement in cardiorespiratory fitness that often accompanies an increase 
in PA. Presently, we found a strong and significant association between daily MVPA and a 
measure of IR (HOMA-IR) after adjusting for confounding variables including cardiorespiratory 
fitness. In contrast, we did not observe the same relationship between cardiorespiratory fitness and 
log HOMA-IR after correcting for the same confounding variables. Together these results 
highlight the potential importance of daily MVPA as a target intervention of improving IR 
independent of changes to cardiorespiratory fitness.     
 
It is clear from previously published longitudinal studies that individuals with greater 
cardiorespiratory fitness are at lower risk for developing diabetes (30, 32). Yet improvements in 
cardiovascular fitness as a result of exercise training are highly variable and can take several 
months to develop (6). Also, while the most robust improvements in cardiovascular fitness stem 
from higher intensity training (8, 10), this kind of activity is also associated with greater participant 
discomfort and injury contributing to higher dropout rates (8). Therefore, it is necessary to 
determine alternative intervention programs that may be more attainable by individuals at risk of 
developing diabetes. Our prediction analysis shows marked improvements in IR with relatively 
modest changes to daily MVPA. Indeed the benefits of cardiorespiratory fitness on other health 
outcomes such as cardiovascular health are undeniable (12, 23), but modest PA may be an 
appropriate alternative for individuals that may see exercise intensity as a barrier to being more 




Near-optimal fasting plasma glucose and insulin levels yield a HOMA-IR value close to 1, and our 
model showed that 120 minutes of MVPA per day predicts near optimal HOMA-IR values.  This 
is equivalent to only 7.5 minutes of activity per hour during wakeful hours (accounting for 8 hours 
of sleep), throughout the day. Some PA guidelines emphasize a bout of at least ten minutes of PA 
to improve health (18). However, our analysis included accumulated minutes of PA throughout 
the entire day. We did not determine how the MVPA was accumulated, and future research is 
required to determine whether MVPA accumulated sporadically throughout the day is sufficient 
to improve IR or if it should be accumulated in bouts to have a positive effect on IR.   
 
Surprisingly, LPA was not significantly associated with IR in our regression models. In contrast, 
similar methods, using objectively measured PA, identical criteria for defining intensity of PA, 
and inclusion of confounding variables like adiposity (i.e. waist circumference or BMI), have 
reported an inverse relationship between LPA and 2-hour plasma glucose concentrations during 
an oral glucose tolerance test (19). This discrepancy between our results and previous analysis may 
be explained by the use of HOMA-IR, which has not been found to be associated with LPA (20). 
Furthermore, while the use of accelerometers are currently the ideal method for measuring PA and 
have a high degree of sensitivity for LPA, HOMA-IR is a less sensitive measure of IR. Therefore 
LPA could have a positive effect on IR that we were unable to detect in our analysis. The use of 
more sensitive measures of IR (i.e. intravenous glucose tolerance test and hyperinsulinemic-
euglycemic clamp methods) may be required to determine the influence of LPA on IR. Further 
investigation into the influence of LPA on IR may have important public health implications for 
individuals incapable or resistant to higher intensity PA.    
 
Obesity is associated with increased risk of IR and type 2 diabetes (21, 29). In our complete model, 
we show that body fat percentage was most strongly associated with IR. With two-thirds of the 
U.S. population classified as overweight or obese, weight loss is an important therapeutic target 
for metabolic disease prevention (15, 16). In fact modest weight loss (~5% of initial body weight) 
can induce clinically relevant improvements in metabolic health (22).  However, clinical trials 
targeting behavioral changes to diet and exercise as well as pharmacological interventions have 
shown only modest weight loss and more importantly have proven difficult to sustain (9). Because 
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sustained weight loss is so difficult for many people (9), adopting a physically active lifestyle may 
be a more feasible alternative to weight loss for those at increased risk of developing IR.     
 
Our study has certain limitations. Because our analysis is cross sectional, causation cannot be 
determined. However, our analysis showed that higher MVPA was indicative of lower IR in 
healthy adults. Large observational trials confirm the association between PA and HOMA-IR (13). 
Controlled intervention trials in which adiposity, cardiorespiratory fitness and PA are manipulated 
independently in a sample large enough to convincingly establish causal association are likely to 
be infeasible. However, a more practical approach may be to systematically determine the 
minimum “dose” (i.e. intensity, duration, caloric expenditure, etc.) of PA, as well as the effect of 
habitual PA over time on the mechanisms underlying an improvement in IR.   
 
It is also important to note that HOMA-IR is not the most sensitive measure of insulin resistance, 
and better measures of insulin resistance exist including an intravenous glucose tolerance test and 
hyperinsulinemic-euglycemic clamp methods.  Although our analysis included a relatively 
insensitive measure of insulin resistance, we were able to detect measurable differences and the 
HOMA-IR method was practical for measuring insulin resistance in a population this large and 
diverse.  
 
The NHANES 2003-2004 survey limited cardiovascular fitness testing to individuals <49 yrs of 
age because of increased risk for an adverse cardiovascular incident. Examining the independent 
relationship between physical activity and cardiovascular fitness on insulin resistance in middle 
and older aged adults is an important question worth pursuing. However, we were unable to make 
this analysis with the current NHANES data set.  
 
Because only healthy adults were selected for this analysis in order to rule out any unnecessary 
confounding factors brought about by disease, on average our sample was more active and fit than 
the average American. While participants averaged nearly 30 minutes of MVPA per day and had 
an estimated VO2max of 40 ± 9 ml-1 •kg -1•min-1, there was a large range of values and high 
variability between participants, suggesting a rather heterogeneous subject pool rather than a 
highly fit population. Although a maximal exercise test was not performed, VO2max was estimated 
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objectively using a submaximal exercise test. Submaximal exercise tests have been shown to be 
strongly correlated with maximal measures of VO2max (14). Also, although the participants in the 
present study were generally younger than the age range where the incidence of newly diagnosed 
type 2 diabetes is greatest (45-64 years old (1)), in order to prevent or delay the onset of diabetes 
it is important to determine how PA behavior may influence IR in younger adults (>45 year old). 
Other than requiring an overnight fast, diet and exercise were also not controlled prior to 
participants’ fasting blood draw or submaximal exercise testing. Although macronutrient meal 
composition and exercise can acutely alter IR (25, 28) it is not unreasonable to assume that 
participant’s diets and exercise habits were not altered during this brief testing period.  
 
Our analysis, using objective measures of PA demonstrated that an increase in daily MVPA had a 
significant and positive effect on IR. Importantly these improvements were independent of other 
variables also known to influence diabetes risk including cardiovascular fitness and adiposity. 
Therefore, if improved glucose metabolism is the primary goal, lifestyle programs targeting 
improvements in metabolic health may be best designed to encourage individuals to participate in 
daily MVPA. This may be particularly important for individuals who have difficulty achieving or 
maintaining weight loss and/or for those who may be deterred by vigorous exercise regimens.   
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Variable Final Cohort 





Mean ± Linearized SE 
(n=481) 
Sex (%)    
   Male 53.0  49.0 
   Female  47.0  51.0 
Race (%)    
   Non-Hispanic white 74.0  68.0* 
   Non-Hispanic black 10.0  14.0* 
   Mexican American 10.0  8.0* 
   Other 7.0  10.0* 
Smoking Status    
   Smokers 29.0  37.0 
   Non-smokers 71.0  63.0 
Age (yrs.) 32.6 ± 0.56 18-49 34.0 ± 0.51* 
Mass (kg) 79.7 ± 1.16 42.8-156.7 82.8 ± 0.95 
BMIa (kg/m2) 26.9 ± 0.26 16.0-50.1 28.3 ± 0.29* 
Body Fat (%) 31.2 ± 0.40 12.2-51.8 33.2 ± 0.42* 
Fasting glucose (mmol/L) 5.1 ± 0.03 3.8-12.1  
Fasting insulin (μU/mL) 9.4 ± 0.49 2.0-61.2  
HOMA-IRb  2.1 ± 0.11 0.2-17.3  
Average MVPAc (min) 32.1 ± 1.23 0.0-134.0  
Estimated VO2maxd 
(ml/kg/min) 
39.7 ± 0.54 21.4-78.9  
 
Table 3-1. Participant demographics, anthropometric, metabolic, physical activity characteristics 
and cardiorespiratory fitness (n=402) 
 
a body mass index 
b homeostatic model assessment of insulin resistance 
c moderate-to-vigorous physical activity  
d maximal oxygen consumption 
*Statistically significant difference between final cohort (n=402) with valid measures of HOMA-
IR, cardiorespiratory fitness, and physical activity and those excluded due to missing or invalid 






Model 1 Model 2 Model 3 Model 4 
Physical Activity (30 min of 
MVPAb) 
-0.2241 -0.1676 -0.0680 -0.1607 
(0.024) (0.072) (0.378) (0.028) 
Estimated VO2max c (ml/kg/min)  -0.0144 0.0035 -0.0008 
 (0.018) (0.613) (0.868) 
Body Fat  (%)   0.0396 0.0789 
  (<0.001) (<0.001) 
Age (yrs.)    -0.01611 
   (0.005) 
Sex Male = 1; Female = 0    -1.0540 
   (<0.001) 
Adjusted r 2 0.042 0.064 0.165 0.423 
r 2 (% change)  52.4% 158% 156% 
 
Table 3-2. Linear regression models predicting log of insulin resistance (log HOMA-IRa).  For 
all models n=402.   
a homeostatic model assessment of insulin resistance 
b moderate-to-vigorous physical activity  








HOMA-IR 95% CI 
0 1.95 1.58-2.32 
15 1.81 1.57-2.06 
30 1.69 1.52-1.86 
45 1.57 1.40-1.73 
60 1.46 1.25-1.69 
75 1.35 1.08-1.63 
90 1.26 0.93-1.59 
105 1.17 0.79-1.55 
120 1.09 0.67-1.51 
 
Table 3-3. Predicted effect of average minutes of MVPAa on HOMA-IRb and 95% confidence 
interval (95% CI) 
 
Predictions are based on Model 4 
 
a moderate-to-vigorous physical activity  
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Health benefits of habitual and acute exercise in overweight-to-mildly-obese adults 
Abstract 
The aims of this study were to compare markers of cardiometabolic disease risk in overweight 
adults who exercise regularly with a well-matched cohort of overweight adults who do not 
exercise, and to assess the metabolic impact of a single session of exercise in these groups. Twenty-
eight overweight-to-mildly obese men and women (BMI: 27-34 kg/m2) were divided into 2 cohorts 
based on their self-reported exercise behavior. 16 of these subjects (male/female: 7/9) were 
classified as exercisers (“EX”) (>2.5h planned endurance-type exercise/week), while 12 subjects 
(male/female: 4/8) were non-exercisers (“Non-EX”). VO2max was significantly greater in EX vs. 
Non-EX (33±3 vs. 25±2 ml/kg/min, p=0.04) but as designed, body mass (89±3 vs. 88±3 kg), 
%body fat (34±1 vs. 37±2%), and waist circumference (100±2 vs. 96±2 kg) were well-matched 
between groups. Participants reported to the laboratory after an overnight fast, and we measured 
resting blood pressure (BP), a fasting blood sample was collected for measures of blood lipids and 
inflammatory cytokines, and insulin sensitivity was assessed using the Matsuda Insulin Sensitivity 
Index (ISI) during an oral glucose tolerance test (OGTT).  Importantly, EX participants refrained 
from exercising for exactly 3 days before the measurements.  After the OGTT, all participants 
performed a single session of exercise (1h at ~70% of their age-predicted HRmax).  They returned 
to the laboratory the next morning for the same measurements performed the day before. ISI was 
significantly higher in EX vs. Non-EX (3.3±0.3 vs. 2.5±0.4; P=0.03), but BP, and blood lipids 
were not different between groups. The acute exercise session increased ISI the next morning in 
Non-EX (2.5±0.4 vs. 3.2±0.6; P=0.01), and this improvement in ISI was significantly correlated 
with the reduction in the plasma concentration of the pro-inflammatory cytokine, IL-1β (P=0.05).  
The exercise session did not increase ISI the next day in EX (3.1±0.2 vs. 3.3±0.5; P=0.56), and as 
a result, ISI was similar between groups the morning after a single session of exercise. In summary, 
exercising regularly (>2.5h/week) was associated with a persistent improvement in insulin 
sensitivity among overweight adults, but not blood pressure or blood lipids. Additionally, just one 
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session of exercise increased insulin sensitivity among sedentary overweight adults to levels equal 
to regular exercisers. 
Keywords: Exercise training, physical activity, sedentary, insulin resistance 
 
Introduction 
Two-thirds of the US adult population are now classified as overweight or obese (33), and 
unfortunately, obesity rates are continuing to rise (34).  Along with the alarming rise in obesity 
rates is the incidence of obesity related cardiometabolic complications including insulin resistance, 
dyslipidemia, hypertension as well as chronic systemic inflammation (85, 97).  Although modest 
weight loss (5-10% of initial body weight) has been found to reduce cardiometabolic disease risk 
(59), even this very modest weight loss can be very difficult to both achieve and sustain (23).  
Alternatively, physical activity/exercise has been highlighted as an important therapeutic tool for 
reducing cardiometabolic disease risk among overweight and obese adults (1).  While regular 
exercise has been identified as a very important factor in delaying and/or preventing 
cardiometabolic disease risk, it is surprising that the factors underlying the health improvements 
associated with regular exercise are still not well understood, particularly in overweight and obese 
adults.  
 
Although a physically active lifestyle is commonly associated with a lower incidence of 
cardiometabolic diseases (45-47, 64), it is often the exercise-induced improvement in VO2max 
(i.e., maximal oxygen consumption) that is credited for the reduced disease risk.  However, 
endurance training has been found to improve measures of insulin resistance, dyslipidemia, and 
blood pressure in overweight and obese individuals in the absence of improved VO2max  (26, 38, 
92).  Additionally, in PROJECT #1 we found that average minutes of daily moderate-to-vigorous 
physical activity, rather than VO2max, was significantly associated with improved insulin 
resistance, suggesting that regular physical activity rather than improved  VO2max helps mediate 
the improvement in cardiometabolic health.  Moreover, the effects of exercise on cardiometabolic 
risk factors (e.g. insulin resistance, hypertension) may be very transient, dissipating after only a 
few days (or less) without exercise (40, 57, 71, 72, 104).  Additionally, evidence also exists to 
suggest that a single session of exercise may improve insulin resistance, as well as reduce blood 
lipids and blood pressure in people who do not exercise regularly (16, 22, 71, 75, 100).  Therefore, 
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although regular exercise is clearly an important contributor to long-term health and disease 
prevention, it remains unclear how much of these health benefits stem from the acute effects of 
the most recent session(s) of exercise, and how much can be attributed to physiologic adaptations 
accrued as a result of habitual exercise. 
 
Obesity is now often characterized as a chronic state of low-grade inflammation, which is linked 
to increased cardiometabolic disease risk, including insulin resistance (8, 90, 102).  Adipose tissue 
is a main source of pro-inflammatory cytokine production in overweight and obese adults.  
Although the regulation and release of pro-inflammatory cytokines from adipose tissue is not 
completely understood, much of the adipose-derived cytokine production in obesity may actually 
be produced in macrophages that infiltrate adipose tissue (49).  Regardless of the source (i.e., 
adipocytes vs. macrophage) obese adults are often found to have elevated plasma concentrations 
of many pro-inflammatory cytokines (e.g., interleukin-6 (IL-6), monocyte chemoattractant 
protein-1 (MCP-1), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β)) (55, 73, 
80, 88).  As described above, exercise can reduce cardiometabolic disease risk but the influence of 
a regular exercise routine and acute exercise on markers of systemic inflammation within 
overweight adults is unclear.  A better understanding of the inflammatory response to habitual and 
acute exercise in overweight and obese adults could have important implications for designing 
lifestyle interventions aimed at reducing cardiometabolic disease risk. 
 
The overall aims of this study were to compare markers of cardiometabolic disease risk in 
overweight adults who exercise regularly with a well-matched cohort of overweight adults who do 
not exercise, and to assess the metabolic impact of a single session of exercise in these groups. In 
general, we hypothesized that the protective effects of regular exercise on cardiometabolic disease 
risk factors would stem largely from the most recent session(s) of exercise.  Along these lines, we 
hypothesized that when overweight adults who exercise regularly were required to abstain from 
exercise for three days, insulin sensitivity, blood pressure, fasting blood lipids, and markers of 
systemic inflammation would be similar when compared with a well-matched cohort of habitually 
sedentary overweight adults.  Additionally, we hypothesized that a single session of exercise would 
induce similar improvements in cardiometablic risk factors measured the next day in both the 




Subjects A total of 28 overweight-to-obese (body mass index [BMI]: 27-34 kg/m2) men (n=11) 
and women (n=17) participated in this study.  Subjects were divided into 2 cohorts based on their 
self-reported habitual exercise.  Sixteen subjects (male/female: 4/8) were classified as “Exercisers” 
(EX; >2.5 h of planned endurance-type exercise/week; male/female: 7/9), while 12 subjects were 
“Non-exercisers” (Non-EX; no planned exercise).  Inclusion criteria included no history of 
metabolic or cardiovascular disease and weight stable (i.e., ± 2 kg for ≥ 6 months).  Participants 
were not taking any medications (with the exception of oral contraceptives).  Female participants 
were scheduled during the follicular phase of their menstrual cycle for the experimental trial.  
Written informed consent was obtained from all subjects prior to participation.  All procedures 
were approved by the University of Michigan Institutional Review Board.  
 
Preliminary testing 
Participants completed a physical activity questionnaire (see APPENDIX 2) in order to classify 
them as either EX (≥2.5h of moderate-to-vigorous exercise/week for >6months) or Non-EX (no 
planned exercise).  Importantly, individuals who reported performing planned exercise between 
≥30min/wk but <2.5h/wk were excluded from the study.  Within one month of the experimental 
protocol, participants completed a sub-maximal exercise test to predict VO2max (as a marker of 
cardiorespiratory fitness) (30).  We also measured each subject’s body composition using 
hydrostatic weighing techinique (17).  
 
All subjects participated in a two-day experimental trial performed on consecutive days (Figure 4-
1).  In order to assess the persistent effects of a regular exercise on our major outcome measures, 
subjects in the EX group abstained from their normal exercise routine exactly 3 days before Day 
1 of the experimental trial, and then abstained from their exercise program until after the 
experiment was complete.  The day before the experimental trial (Day 0), all participants wore a 
pedometer (New Lifestyles, Lee’s Summit, MO) and were instructed to remain relatively sedentary 
by completing <5000 steps per day (94).  Participants also wore an ambulatory blood pressure 
monitor (A&D Company, Tokyo, Japan) – to assess blood pressure every 30 minutes between 
2pm-10pm during the afternoon/evening before the experiment.  A standardized meal (30% of 
total daily energy requirements; ~750kcals) eaten at 1800h and a standardized snack (~10% of 
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daily energy requirements) eaten at 2100h were provided to participants and they consumed only 
water for the remainder of Day 0.   
 
Subjects returned to the laboratory at 0700h the next morning after an overnight fast (Day 1).  After 
resting quietly for 30 minutes, a resting blood pressure measurement was obtained (A&D 
Company, Tokyo, Japan).  We then placed an intravenous (IV) catheter in an arm vein and 
collected a baseline blood sample to determine plasma substrate and hormone concentrations (i.e. 
glucose and insulin), blood lipid profile (i.e., plasma concentrations of HDL-C, LDL-C, total 
cholesterol, triglycerides, fatty acids), and plasma markers of systemic inflammation (i.e., TNF-α, 
IL-1β, IL-6, and MCP-1).  After the baseline blood sample was withdrawn we performed a two-
hour oral glucose tolerance test (OGTT) with a 75g glucose load (Glucose Tolerance Test 
Beverage, Fisher Scientific).  Blood samples were collected every 15 minutes for the duration of 
the test.  After the OGTT, the IV was removed and participants were provided a standardized 
breakfast (see “Study diets” section below) and rested quietly.  At noon, participants performed a 
session of exercise on a treadmill for 1 hour at a moderate intensity equal to 70% of their age-
predicted heart rate max (HRmax).  After completing the exercise session, subjects were provided 
a standardized lunch, eaten in the laboratory.  They were also provided another standardized meal 
and a snack to be eaten at home at 1800h and 2100h, respectively. Identical to the afternoon of 
Day 0, participants again wore a pedometer and ambulatory blood pressure monitor.  Subjects 
returned to the laboratory at 0700h the next morning (Day 2) after an overnight fast – at which 
time we measured their resting blood pressure, collected a baseline blood sample and performed 
another 2 h OGTT to determine the responses the day after a single session of exercise in both 
cohorts.   
 
Study diets 
Importantly, diets were designed to maintain "energy balance" (i.e.; energy intake = energy 
expenditure) to avoid the confounding influence of a negative energy balance on insulin sensitivity 
(5).  In the evening of Day 0 (i.e., the evening before the experiment), the total energy content of 
the standardized dinner and snack were ~30% and ~10% of estimated daily energy expenditure, 
which was assessed using calculations from Cunningham, et al., (20).  Because the exercise session 
on Day 1 increased daily energy expenditure, we calculated Day 1 energy expenditure for each 
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participant as follows: ([(VO2 during exercise) x (5kcal/liter of O2 consumed) x 60min + [(1.5 x 
(370+(21.6*FFM))) x (1380min)]), and energy intake on Day 1 was provided to match this 
calculated energy expenditure. On Day 1, breakfast (including the OGTT), lunch, and dinner each 
contained ~30% of participants estimated daily energy expenditure.  The evening snack contained 
~10% of participants estimated daily energy expenditure.  After the evening snack on Day 0 and 
Day 1, subjects did not eat anything until completion of the OGTT the next day.  The macronutrient 
composition of meals and snacks was: 55% carbohydrate, 30% fat, and 15% protein, which 
represents the macronutrient content of a “typical” western diet (9). 
 
Analytical procedures 
Plasma substrate and hormone concentrations  
Blood samples were collected in chilled EDTA tubes, centrifuged (1,600 g for 20 min. at 4°C) 
within 30 min of collection, and then stored at -80°C until analysis.  Plasma glucose (glucose 
oxidase assay; Thermo Fisher Scientific, Waltham, MO), fatty acid (NEFA-HR assay kit; WAKO 
Life Sciences, Inc., Richmond, VA), triglyceride (Triglyceride Reagent; Sigma Adrich, St. Loius, 
MO), total- and high-density lipoprotein (HDL; Cholesterol E and HDL-Cholesterol E; WAKO 
Life Sciences, Inc.) concentration were measured with commercially available colorimetric assay 
kits. Plasma insulin concentration was measured using a commercially available 
radioimmunoassay (RIA) kit (Human insulin RIA kit; EMD Millipore, Billerica, MA). Plasma 
markers of systemic inflammation (e.g. TNF-α, IL-1β, IL-6, and MCP-1) were measured using 
commercially available Multiplex magnetic bead kits (EMD Millipore) and the Luminex L200 
instrument (Luminex, Austin, TX).  Data from the Multiplex bead kits were quantified using 
xPONENT software (Luminex).  All assay kits were used per manufacturer instructions.   
 
Calculations 
Index of whole body insulin sensitivity: Plasma glucose and insulin concentrations measured 
immediately before and during the OGTT were used to assess insulin sensitivity using the Matsuda 
Composite Index (69).  The Matsuda Composite Index has been found to be a reasonably accurate 




𝑀𝑎𝑡𝑠𝑢𝑑𝑎 𝐶𝑜𝑚𝑝𝑜𝑠𝑖𝑡𝑒 𝐼𝑛𝑑𝑒𝑥 
= 10000/√[(fasting insulin x fasting glucose)x (2h glucose x 2h insulin) 
 
We also calculated whole-body insulin resistance using the Homeostatic Model Assessment of 
Insulin resistance (HOMA-IR), which provided a supplementary index of insulin action in our 
subjects (105).   
 
𝐻𝑂𝑀𝐴 − 𝐼𝑅 = (𝑓𝑎𝑠𝑡𝑖𝑛𝑔 𝑝𝑙𝑎𝑠𝑚𝑎 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 𝑥 𝑓𝑎𝑠𝑡𝑖𝑛𝑔 𝑝𝑙𝑎𝑠𝑚𝑎 𝑖𝑛𝑠𝑢𝑙𝑖𝑛)/22.5) 
 
Low density lipoprotein cholesterol concentration (LDL-C): Plasma LDL-C was calculated from 
measurements of plasma concentrations of total cholesterol (Total-C), HDL-C, and triglyceride 
 
[LDL-C] = ([Total-C] – [HDL-C] – [Triglyceride])/5 
 
Percent body fat: Body volume and density were assessed by hydrostatic weighing technique 
and the Siri equation was used to determine body fat percentage (17). 
 
Statistical analysis   
Student’s t-tests were used to compare baseline characteristics between participants in our EX and 
Non-EX cohorts.  A two-way ANOVA with one factor repeating (group x day) with Tukey post-
hoc analysis was used to assess significant differences in insulin sensitivity, blood pressure, 
markers of systemic inflammation, and plasma lipid concentrations between cohorts and in 
response to the single session of exercise. ISI was not normally distributed and was therefore log 
transformed prior to statistical analysis (untransformed data are presented).  A P-value of ≤ 0.05 




Subject characteristics and intensity during the experimental exercise session 
As designed, subjects in our EX and Non-EX cohorts were very well matched for body weight, 
BMI, and body composition (Table 4-1), but there was a great disparity in the planned exercise 
between the groups.  While our Non-EX subjects reported no planned exercise our EX group 
averaged >32 MET-hours per week of planned exercise (Table 1).  In conjunction with their greater 
habitual exercise, VO2max in EX was 36% greater than Non-EX (P<0.05; Table 4-1).   The 
exercise session on Day 1 of the study was performed at the same relative intensity in the EX and 
Non-EX subjects (i.e., same %HRmax and same %VO2max; Table 4-2). However, because of the 
difference in VO2max between the groups, the absolute exercise intensity in EX tended to be 
greater than Non-EX, as noted by a trend for a higher absolute VO2 during exercise (Table 4-2) 
and total energy expended during exercise (468 ± 42 vs. 384 ± 35 kcals for EX and Non-EX, 
respectively), but differences between groups did not reach statistical significance (P=0.15). 
 
Insulin Sensitivity Index 
Insulin sensitivity in our subjects appeared to be influenced by their habitual physical activity 
behavior.  Despite similar body weight and adiposity, Insulin Sensitivity Index (ISI) was 
significantly higher in EX than Non-EX (Figure 4-2).  Importantly, the EX participants abstained 
from exercise for 3 days in order to washout the effects of their most recent session of exercise. 
The calculation of HOMA-IR supported the notion that insulin sensitivity was higher in our EX 
vs Non-EX subjects (HOMA-IR: 3.4 ± 0.3 vs. 4.5 ± 0.5, respectively; P=0.05).  Importantly, the 
single session of exercise performed in the afternoon of Day 1 of the experiment increased ISI the 
next morning in Non-EX, but not EX (Figure 4-2). As a result of this increase in ISI only in the 
Non-EX group, there was no longer a difference in ISI between EX and Non-EX the day after the 
single session of exercise (Day 2).     
 
Markers of Systemic Inflammation 
In the morning of Day 1 of the experiment, fasting plasma concentrations of IL-6, MCP-1, and 
TNF-α were not different between Non-EX and EX (Figure 4-3 A-C).  In contrast, IL-1β tended 
to be higher in Non-EX compared with EX on Day 1, but this did not quite reach statistical 
significance (2.9±0.7 vs. 5.2±1.3, P=0.09, Figure 4-3 D). Interestingly, the improvement in ISI 
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found the morning after acute exercise in our Non-Ex group was significantly correlated with the 
change in plasma IL-1β concentration (P=0.05; Figure 4-4). There was no such relationship 
between the change in ISI and any of the other inflammatory markers measured for either the EX 
or Non-EX subjects. 
 
Blood Pressure and blood lipid profile 
Habitual physical activity did not appear to affect blood pressure in our subjects because both 
resting and ambulatory blood pressures were very similar between EX and Non-EX on Day 1 
(Figure 4-5).  The single session of exercise reduced resting diastolic blood pressure the next 
morning, but this reduction only reached statistical significance in the EX cohort (Figure 4-5 B).  
We also found a trend for ambulatory systolic blood pressure to be reduced following a single 
exercise session in the Non-EX group but this did not reach statistical significance (P=0.10; Figure 
4-5 C). Although regular exercise is often associated with reduced cardiovascular disease risk (28), 
we did not detect differences in blood lipids (i.e., Total-C, HDL-C, LDL-C, triglyceride) between 
our EX and Non-EX groups, and the acute exercise session also did not significantly alter the 
plasma concentration of these blood lipids in either group (Table 4-3). We did observe a very 
slight, yet significant reduction in fasting plasma NEFA concentration the morning after a single 
session of exercise in our EX cohort (Table 4-3). 
 
Discussion 
A physically active lifestyle is widely identified as being an important contributor to improved 
health and disease prevention (47, 106).  However, it is still unclear whether these health benefits 
stem largely from acute responses to the most recent session(s) of exercise or from more persistent 
effects due to physiological adaptations that accrue in response to regular exercise.  Our findings 
indicate that in contrast to our hypothesis, overweight adults who exercise regularly were more 
insulin sensitive than their well-matched sedentary counterparts, even when the acute effects of 
exercise were removed by abstaining from exercise for 3 days.  Therefore, unlike findings from 
studies indicating that the insulin sensitizing effects of exercise training wear off after even a few 
days without exercise (40, 57, 71, 72, 81, 103), we found a persistent effect of regularly performed 
exercise on insulin action in our weight-stable overweight adults.  Interestingly, we also found that 
a single session of relatively moderate-intensity exercise did not further enhance the insulin 
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sensitivity index (ISI) the next morning in these subjects who were already regular exercisers.  In 
contrast, the single exercise session did increase ISI the next morning in our habitually sedentary 
subjects, and this improvement in ISI was associated with a reduction in the systemic pro-
inflammatory factor IL-1β.  This suggests that the insulin sensitizing effect of acute exercise in 
overweight adults who do not regularly engage in exercise, may be mediated in part by a reduction 
in their systemic inflammatory state. 
 
Many studies report that the increase in insulin sensitivity with exercise training is very transient, 
often returning to levels found in non-exercisers after only three days without exercise (40, 57, 71, 
72, 81, 103).  In contrast, we found that ISI was elevated in our group of exercisers compared with 
their well-matched cohort of non-exercisers, even when they did not exercise for a few days. It is 
conceivable that some of this discrepancy between our findings and these previous studies may be 
explained by the possibility that some effects of acute exercise may still persist 3 days after the 
exercise in our habitually active subjects.  However, Oshida al., (81) reported that the acute effects 
of exercise on insulin action were gone 38h after the most recent session of exercise. Perhaps more 
importantly, these earlier studies reporting short-lived improvements after exercise were largely 
performed in lean subjects (40, 57, 71, 72, 81, 103), and the response in overweight adults may be 
different.  In lean humans and animals, the exercise-induced reduction in muscle glycogen is 
associated with the enhanced insulin action found after exercise (12, 31, 84).  For example, in lean 
animals the time course of muscle glycogen resynthesis after exercise tracks very closely with the 
time course of the transient exercise-mediated increase in insulin sensitivity (14).  Alternatively, 
because insulin action is often found to be impaired in overweight/obese adults (10, 11) it seems 
plausible that habitual exercise in overweight adults may induce some longer lasting adaptations 
that may counteract their insulin resistance.  Several studies suggest that an exercise-induced 
increase in oxidative capacity may contribute to an improvement in insulin action by increasing 
oxidative disposal of fatty acids – thereby reducing the accumulation lipid intermediates known to 
impair insulin signaling (56, 82, 98, 99).  But the impact of an increase in oxidative capacity on 
resting fatty acid metabolism and insulin sensitivity is debated (35, 43, 44, 101).  Alternatively, a 
previous study from our lab (89) reported that exercise altered the metabolic fate of the fatty acids 
within skeletal muscle by enhancing storage as neutral lipid rather than accumulation of the other 
lipid intermediates known to impair insulin signaling (42).  Alterations in muscle fatty acid 
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metabolism may be especially relevant in overweight/obese adults, and may extend (and perhaps 
prolong) their exercise-induced improvement in insulin sensitivity beyond the effects of lower 
muscle glycogen concentration.  However, the improvement in insulin resistance with habitual 
exercise in overweight/obese adults may not be isolated to adaptations occurring exclusively in the 
exercising muscles.  For example, hepatic insulin resistance has been found to improve with 
exercise training (58).  Additionally, exercise training in obese adults has been found to increase 
adiponectin (54), an adipose tissue-derive cytokine known to enhance whole body insulin 
sensitivity (66).  Therefore, regularly performed exercise in overweight/obese adults induces 
adaptations in multiple tissues that may contribute to a more persistent improvement in insulin 
sensitivity, even after the exercise-induced reduction in muscle glycogen concentration has been 
replenished.  
 
Consistent with previous reports (22, 71, 75) we found that a single session of exercise was 
sufficient to improve insulin sensitivity the next day in overweight adults who do not exercise 
regularly.  In contrast, we did not observe an improvement in ISI after exercise in regular 
exercisers, and as a result, the difference in ISI between groups was no longer apparent the day 
after exercise.  The mechanisms underlying the improvement in ISI in response to chronic vs. acute 
exercise are likely very different (described in more detail below).  However, the clinical relevance 
of this finding is intriguing because it suggests that when compared with the enhanced insulin 
action stemming from exercising routinely, a similar degree of improved insulin action can be 
achieved immediately, without having to wait for the accrual of adaptations in response to months 
or years of exercise training.  Over time, as an individual adopts a more active lifestyle, the 
mechanisms underlying the exercise-induced improvement in insulin action may change, but the 
clinical outcome remains the same (i.e., improved insulin sensitivity).  However, it is important to 
note that the ISI measured in our group of regularly exercising overweight subjects or after acute 
exercise in our non-exercisers were still less than half of values reported in sedentary lean adults 
(27, 51, 60, 76).  Therefore, while exercise is clearly an important therapeutic tool for reducing 
metabolic disease risk among overweight-to-mildly obese adults, important additional benefits 




The reason why the single session of exercise did not enhance insulin action in our habitually 
active participants is unclear. Perhaps the exercise stimulus in our study was below some 
“threshold” required to further enhance insulin action the next day in these subjects who exercise 
regularly.  Factors determining the magnitude of an exercise stimulus that may be required to 
improve insulin sensitivity are not clear, but certainly the intensity, duration, and energy expended 
during exercise are likely candidates.  Exercise intensity is a major determinant for the magnitude 
of muscle glycogen used during exercise (87), and as described above, the exercise-induced 
reduction in muscle glycogen concentration is often observed along with the increased insulin 
sensitivity after exercise (108).  Importantly, because habitual exercise training is known to 
markedly reduce the contribution of muscle glycogen use during exercise (50, 87), this may help 
explain the lack of an acute effect of exercise on ISI in our habitually active subjects.  The fact that 
the single exercise session performed in our study provided a considerably lower exercise stimulus 
than what our participants who regularly exercise reported to perform on a regular basis may also 
contribute to our finding that acute exercise did not increase ISI in this regularly exercising  cohort.  
The acute 1h session brisk walking in our study was equal to approximately 4.5 METs, whereas 
on average our active subjects reported participating in an hour of exercise at an intensity equal to 
over 6 METs.  Therefore, an exercise stimulus closer to, or perhaps even greater than, that 
performed regularly may be required to further enhance insulin action in a group of overweight-
to-obese adults who exercise routinely.  This notion is generally consistent with the progressive 
overload principle (41) indicating that a progressive increase in “stress” must be provided to induce 
physiological changes/adaptations.  It is also important to note that because our assessment of 
insulin sensitivity was based on established calculation using plasma glucose and insulin 
concentrations during and OGTT (69) rather than more sensitive measures, like a 
hyperinsulinemic-euglycemic clamp (21), it is possible we were unable to detect a relatively subtle 
improvement in insulin sensitivity the day after an acute session of moderate-intensity exercise in 
our cohort of regular exercisers. 
 
Pro-inflammatory cytokines, including: IL-1β, IL-6, TNF-α, and MCP-1, are associated with 
insulin resistance (78, 90), and plasma concentrations of these cytokines are often found to be 
elevated in overweight and obese adults (55, 67).  Weight-loss is consistently found to lower the 
systemic abundance of many of these pro-inflammatory cytokines in conjunction with 
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improvements in insulin sensitivity (29, 61).  Similarly, when exercise training is accompanied by 
weight loss the improvement in insulin sensitivity has been found to parallel the reduction in 
systemic inflammatory markers (24, 32).  However, the effect of exercise without weight loss is 
less clear.  Although plasma concentrations of most of the systemic inflammatory markers we 
measured were not affected by exercise training or acute exercise in our study, IL-1β tended to be 
lower in our subjects who were habitual exercisers.  Importantly, the exercise-induced 
improvement in ISI we found the day after the acute session of exercise in Non-Ex was related to 
the change in plasma IL-1β concentration.  IL-1β is a pro-inflammatory cytokine primarily 
produced and secreted by monocytes, macrophages, and neutrophils.  IL-1β secretion is elevated 
in obesity, and accumulating evidence implicates IL-1β in the pathogenesis of insulin resistance 
(36, 70, 77, 96).  It has been suggested that IL-1β may impair insulin action in skeletal muscle by 
activating other pro-inflammatory signaling pathways such as the Nuclear factor kappa-B (NF-
κB) pathway (2), which is known to reduce insulin signaling (48).  The effects of exercise on IL-
1β are complex.  A one-year intensive exercise training intervention involving both endurance- 
and resistance-type exercise has been found to lower plasma IL-1β concentration in obese patients, 
independently of changes in weight or body fat (7).  Our finding that the trend for a lower plasma 
IL-1β in our habitual exercisers vs. non-exercising overweight adults did not reach statistical 
significance suggests that perhaps the regular exercise may need to be rather intensive in order to 
see a more robust effect on plasma IL-1β concentration, as suggested by Balducci, et al, (7).  Acute 
exercise also has important effects on IL-1β.  In lean healthy adults, plasma IL-1β concentration 
has been found to increase during a session of exercise in lean, healthy adults – and then return to 
pre-exercise levels soon after exercise (and remains at basal levels in the days after exercise) (91).  
But our finding that acute exercise lowered plasma IL-1β the day after exercise in our group of 
non-exercising overweight subjects suggests the effects of acute exercise in overweight adults who 
already exhibit elevated plasma IL-1β may be different, and this lowering of IL-1β may contribute 
to their exercise-induced improvement in ISI.  This is in agreement with findings from a recent 
study in obese rodents in which a single session of exercise reduced IL-1β mRNA expression in 
adipose tissue (in both adipocyte and stromal vascular fractions), with a resultant decline in plasma 
IL-1β concentration that was accompanied by an enhanced systemic insulin sensitivity (79).  
Therefore, although causality cannot be determined in the current study, our results support the 
growing body of literature highlighting the role of pro-inflammatory cytokines, such as IL-1β, in 
65 
 
the pathogenesis of insulin resistance among overweight adults as well as a contributing 
mechanism by which exercise leads to an improvement in whole body insulin sensitivity. 
 
Although exercise training and a higher cardiorespiratory fitness (i.e., VO2max) are both 
commonly linked with reduced risk for cardiovascular disease (47, 62, 63, 106), we found subjects 
blood lipid profile and blood pressure to be similar between our exercisers and non-exercisers.  
While many studies report that exercise training can improve blood lipid profile and lower blood 
pressure (25, 107), others do not (15, 95).  Even in studies that report exercise-induced 
improvement, these changes are often very modest (53, 68).  For example, meta-analysis from 
randomized control trials indicate that on average exercise training lowered LDL-C concentration 
by only 0.16 mmol/L and increased HDL-C by only 0.04 mmol/L (39). Additionally systolic and 
diastolic blood pressure appear to only be reduced by < 5 mmHg with exercise training (53).  More 
consistent improvements in blood lipids and blood pressure are observed in individuals who show 
signs of dyslipidemia and hypertension (13, 18), but these improvements are still rather modest 
(e.g., 2 mg/dL increase in HDL-C and 5-7mmHg reduction in systolic blood pressure (25, 65)).  
Importantly diet-induced weight loss promotes robust and consistent improvements in blood lipids, 
blood pressure and other markers of cardiovascular disease risk (52, 68).  These findings further 
emphasize that exercise without weight loss may not be an optimal therapeutic approach for 
improving blood lipids and blood pressure in overweight adults.  It is possible that many of the 
improvements in cardiovascular risk factors reported in response to regularly performed exercise 
may stem from the most recent session of exercise.  For example, a single session of exercise has 
been consistently found to lower blood pressure (albeit slightly; systolic: 6-10mm Hg, diastolic: 
2-5 mmHg) in just the first few hours after exercise (74, 86, 93).  However, this effect appears to 
be fairly short lived, lasting 4-6 hrs in normotensive individuals (104) and 10-12 hrs post-exercise 
in hypertensive individuals (83).  Acute exercise has also been shown to produce meaningful 
reductions in plasma triglyceride levels, yet this appears to be largely dependent on higher energy 
expenditure associated with prolonged exercise (3, 19).  In contrast, cholesterol levels appear to 
be largely non-responsive to a single session of exercise regardless of exercise intensity or energy 
expenditure (37, 109).  Collectively our findings suggest that neither acute nor regular exercise 
induced robust improvements in these markers of cardiovascular risk among overweight, but 
otherwise, healthy adults.  In combination with previous findings demonstrating little if any 
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improvement in cardiovascular disease risk with physical activity/exercise a more therapeutic 
approach for reducing cardiovascular disease risk among overweight adults may be to promote 
weight loss especially considering that modest reductions in weight are associated with clinically 
relevant improvements in health within this population (59). 
 
Assessing the direct contribution of regular exercise on important clinical outcomes like insulin 
resistance, blood lipids and blood pressure can be very challenging.  For example, because a minor 
reduction in body weight can markedly increase insulin sensitivity (59) if exercise is accompanied 
by even a subtle degree of weight loss this would confound the interpretation of the underlying 
cause for the improvement in insulin resistance.  Along these lines, reports of improvements in 
insulin action resulting from an exercise training program that persisted for over two weeks after 
the last exercise training session (6) may actually be due to participants  slight, yet significant 
weight loss.  Moreover, an acute negative energy balance  (i.e., energy expenditure exceeds energy 
intake) that may result from a more physically active lifestyle can also acutely improve insulin 
sensitivity (4) independently of the effects of an increase in physical activity.  Additionally even 
modest weight loss can have clinically meaningful reductions in plasma lipids and blood pressure 
(59).  Therefore, in these conditions it is often impossible to differentiate the effects of this weight 
loss and/or energy imbalance from the effects of the increased physical activity.  Although our 
cross-sectional study design certainly has limitations, we were very strict about weight stability 
among all of our subjects, and we tightly matched key phenotypic characteristics of our group of 
regular exercisers and non-exercisers (e.g., body weight, body composition, waist circumference), 
which increases confidence regarding the independent effects of regular exercise on ISI and the 
other clinical outcomes that we reported here.  Understanding the independent effects of exercise 
behavior (separate from the effects of weight loss and negative energy balance) on important health 
outcomes is very valuable in the development of lifestyle programs aimed at improving metabolic 
health. 
The overall objective of this study was to help distinguish between the cardiometabolic health 
benefits associated with habitual exercise and those stemming from the most recent session of 
exercise in weight-stable overweight-to-mildly-obese adults.  We found that engaging in a regular 
exercise routine was associated with a persistently elevated insulin sensitivity index in overweight 
adults, but not with a reduction in other key cardiometabolic disease risk factors (i.e., blood lipids 
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or blood pressure).  While the mechanism(s) underlying the persistent effect of regular exercise on 
insulin sensitivity among overweight adults is not clear, alterations in muscle lipid metabolism as 
well as adaptations in tissues other than muscle (i.e., liver and adipose) may be contributing.  In 
response to a single session of moderate-intensity exercise, insulin sensitivity index improved the 
day after exercise in overweight adults who do not normally exercise, but not in those who exercise 
regularly.  As a result the difference in insulin sensitivity between our group of regular exercisers 
and non-exercisers was largely eliminated.  The exercise session lowered plasma IL-1β 
concentration in the habitually sedentary overweight subjects, suggesting a reduction in systemic 
inflammation may contribute to their enhanced insulin action after exercise.  Therefore, while 
habitual exercise is associated with enhanced insulin sensitivity among overweight adults, just one 
session of exercise was enough to increase insulin sensitivity among sedentary overweight adults 
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Table 4-1. Baseline participant characteristics 
  EX Non-EX 
Sex (M/F) (7/9) (4/8) 
Age (y) 26.2 ± 1.3 28.1 ± 1.9 
Body weight (kg) 89.4 ± 2.7 88.4 ± 2.5 
BMI (kg/m2) 30.5 ± 0.8 30.0 ± 0.5 
Body fat (%) 33.5 ± 1.4 36.8 ± 2.0 
Fat mass (kg) 30.2 ± 1.9 32.4 ± 1.8 
Fat free mass (kg) 59.2 ± 1.8 56.0 ± 2.5 
Fasting glucose (mmol/L) 4.3 ± 0.1 4.6 ± 0.1 
Fasting insulin (uU/mL) 17.6 ± 1.5 22.3 ± 2.6 
VO2max (ml/kg/min) 32.9 ± 2.8 24.2 ± 1.7* 
Planned exercise (MET-hours per week) 32.3 ± 2.6 0.0 ± 0.0* 
Values are expressed mean ± SE 






Table 4-2. Oxygen consumption and heart rate during the exercise session 
  EX Non-EX 
VO2 during exercise (L/min) 1.6 ± 0.2 1.3 ± 0.1 
VO2max (%) 53.5 ± 2.5% 60.3 ± 4.1% 
Heart rate (bpm) 140.1 ± 2.3 138.3 ± 1.8 
Predicted HRmax (%) 72.1 ± 0.9% 71.8 ± 0.7% 





Table 4-3. Fasting plasma substrate, hormone, and lipid profile 
  EX Non-EX 
 Day 1 Day 2 Day 1 Day 2 
Glucose (mmol/L) 4.3 ± 0.1 4.3 ± 0.1 4.6 ± 0.1 4.5 ± 0.1 
Insulin (uU/mL) 17.6 ± 1.5 18.5 ± 1.2 22.3 ± 2.6 19.3 ± 2.7† 
Total-C (mg/dL) 148 ± 9 147 ± 8 153 ± 7 151 ± 6 
LDL-C (mg/dL) 121 ± 10 121 ± 9 122 ± 8 121 ± 6 
HDL-C (mg/dL) 27 ± 2 26 ± 2 31 ± 3 30 ± 3 
Triglyceride (mg/dL) 111 ± 14 118 ± 15 84 ± 10 91 ± 11 
NEFA (µmol/L) 407 ± 36 328 ± 28‡ 418 ± 46 399 ± 42 
Total Choleserol, Total-C; Low-density lipoprotein cholesterol, LDL-C; High-density 
lipoprotein cholesterol, HLD-C.  Values are expressed mean ± SE. † Significant 
difference between Day1 and Day 2 within Non-EX, P<0.05. ‡ Significant difference 
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Progressive metabolic adaptations to low intensity exercise training in obese adults 
 
Abstract 
The aim of this study was to examine the progressive adaptations that occur after 1 session, 2 
weeks, and 3 months of low-intensity exercise in previously sedentary obese adults.  Ten sedentary 
obese adults (men/women: 3/7; 38±1 kg/m2; 30±3 yrs) completed 5 experimental trials: 1) before 
beginning the exercise program (“PRE”), 2) after a single session of low-intensity exercise (40min 
at 60% HRmax), 3) after 2 weeks (6 days/wk) of this same exercise (“2WKS”), 4) again after 3 
months of training (“3M”), and 5) exactly 3 days after the their last session of the 3 month exercise 
training program (“3d after EX”).  We performed a meal tolerance test 1h after exercise (or without 
prior exercise in “PRE” and “3d after EX”) to calculate the “insulin sensitivity index” (ISI) in the 
few hours after exercise, and we performed a hyperinsulinemic-euglycemic clamp the next 
morning ~16 hr after exercise (or without prior exercise in “PRE” and “3d after EX”). We also 
measured fatty acid oxidation, as well as total and LDL cholesterol. We found a single session of 
exercise did not significantly alter any of our primary outcome measures.  However, by 2WKS ISI 
(2.1±0.2 vs. 2.4±0.2; P=0.02) and hepatic insulin resistance (33±4 vs. 27±2; P=0.03) were 
improved in the few hours after exercise.  ISI did not improve further after 3 months of the exercise 
program.  By 3 months of training, we observed a trend for an improvement in insulin sensitivity 
measured via the clamp the day after exercise, but this did not quite reach statistical significance 
(Glucose Rd/SSI: 2.4±0.3 vs. 2.9±0.3 (mg/min)/[SSI]; P=0.065).  This trend for improved insulin 
sensitivity was no longer apparent 3d after EX.  The exercise training program also increased fatty 
acid oxidation during exercise (8.6±1.3 to 11.8±1.7 µmol/kgFFM/min (P<0.01)) and at rest 
(3.8±0.2 to 4.5±0.3 µmol/kgFFM/min (P=0.02)) by 2WKS, and remained elevated throughout 3 
months of training.   Three months of training also significantly reduced Total-C (184±11 vs. 
163±7 mg/dL) and LDL-C (152±11 vs. 131±9 mg/dL) (both P<0.05). Importantly, all adaptations 
were independent of any change in body mass (108±4 vs. 108±5 kg) or fat mass (52±3 vs. 53±4 
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kg). In summary, although a single 40 min session of exercise performed at 60%HRmax was not 
sufficient to induce any measurable changes in our markers of cardiometabolic health, we did find 
improvements in insulin sensitivity by 2 weeks as well as improvements in blood cholesterol by 3 
months of this mild exercise training program in weight-stable obese adults.  
Keywords: Insulin resistance, glucose tolerance, physical activity 
 
Introduction 
Most current exercise recommendations are designed with the goal to improve cardiorespiratory 
fitness (e.g. maximal oxygen uptake (VO2max)) (1).  However, mounting evidence suggests many 
health benefits of exercise are largely independent of improvements in “fitness” (13, 22, 27).  
Along these lines, in PROJECT #1 of my dissertation we found that daily physical activity was a 
strong and significant predictor of insulin resistance, but VO2max was not.  These findings support 
the notion that a training program specifically designed to increase VO2max may not be optimal 
for improving metabolic health.  Moreover, exercise prescriptions that focus on enhancing 
VO2max may actually be counter-productive because the higher intensity exercise often required 
to improve VO2max has been associated with a greater incidence of injuries and participant 
discomfort leading to poor exercise adherence (23).  In contrast to the relatively high intensity 
exercise required to improve VO2max, profound reductions in cardiometabolic disease risk result 
from engaging in rather low or modest intensity physical activity (42).   
 
Although adaptations to a physically active lifestyle can certainly improve important health 
outcomes, many cardiometabolic health benefits of exercise actually stem from the most recent 
exercise session(s), rather than from adaptations to weeks, months, and even years of exercise (22, 
57, 61, 70, 72).  In PROJECT #2 of my dissertation, although we did find that habitual exercise 
resulted in some persistent improvement in insulin sensitivity, we found a single session of 
moderate intensity exercise improved insulin sensitivity the next day in overweight-to-mildly-
obese adults, which is in line with several previous reports (22, 57, 61).  Our findings from 
PROJECT #2 also suggest that metabolic responses to an exercise session in overweight adults 
who do not exercise regularly are different from those who do exercise regularly.  Therefore, 
adaptations that accrue as a non-exerciser begins to adopt a more physically active lifestyle appear 
to impact the metabolic response to each exercise session.  However, the underlying mechanisms 
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that lead to improvements in health in the early stages of adopting a mild exercise training program 
remain unclear. 
 
An important link between obesity and the development of insulin resistance (and many other 
metabolic diseases) is the overly-abundant mobilization of fatty acids in the circulation – and the 
subsequent delivery and uptake of excessive amounts of fatty acids into insulin-responsive tissues 
like skeletal muscle and liver.  Consequently, this overabundance of fatty acid can result in the 
accumulation of fatty acid by-products in these tissues that can activate pro-inflammatory 
pathways, which in turn can induce insulin resistance (10).  A previous study from our laboratory 
demonstrated that exercise can alter the metabolic fate of fatty acids that enter the muscle cell, 
thereby reducing the accumulation of lipid intermediates (e.g., DAG and ceramide) known to 
impair insulin signaling (74).  However, this earlier study was performed in lean subjects who 
were exposed to an overnight lipid infusion after a session of vigorous exercise (74).  More recent 
findings from our lab indicate that when obese subjects exercised at a relatively low intensity (50% 
VO2max) the changes in muscle lipid metabolism were far less robust, and skeletal muscle pro-
inflammatory stress was not reduced (61).  This recent study (61) only examined the effects of a 
single session of low intensity exercise, and it is possible that at least a few successive sessions of 
exercise at these low intensities may be required to impart a measurable effect on muscle lipid 
metabolism and inflammatory pathway activation.  Additionally, exercise-induced changes in 
inflammatory status within adipose tissue and the systemic circulation may contribute to 
improvements in insulin resistance as well as other cardiometabolic diseases risk factors (34, 62, 
76).  Importantly a better understanding of the progressive adaptations associated with adopting a 
low-intensity exercise training program on fatty acid metabolism, pro-inflammatory pathways, and 
ultimately on insulin resistance, could have important implications for designing lifestyle 
interventions aimed at reducing cardiometabolic disease risk in obese adults.   
 
The overall aim of this study was to examine the progressive adaptations that occur after 1 session, 
2 weeks, and 3 months of adopting a low-intensity exercise program in previously sedentary obese 
adults.  We hypothesized that a single session of mild intensity exercise would not be sufficient to 
improve insulin resistance the next day.  However, we did anticipate insulin resistance would 
improve after 2 weeks of exercise with no further improvement after 12 weeks.  We predicted that 
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reductions in both the accumulation of fatty acid by-products and pro-inflammatory activation 
within muscle would parallel the improvement in insulin action.  Finally, we hypothesize that 
insulin resistance would return to pre-training levels when participants abstain from exercise for 




A total of 10 obese males (n=3) and females (n=7) (body mass index [BMI]: 37 ±1 kg/m2; age: 
30±3 yrs) were recruited to participate in this study.  We performed a detailed health history, 
physical examination, as well as a 12-lead electrocardiogram, and standard blood and urine tests.  
Participants were not taking any medication known to influence the metabolic parameters we were 
measuring.  All subjects were non-smokers, weight stable (i.e., ± 2 kg for ≥ 6 months), sedentary 
(no regularly planned exercise/physical activity), and had no health history of metabolic or 
cardiovascular diseases.  Written, informed consent was obtained from all subjects before initiating 
participation.  All procedures of this study were approved by the University of Michigan 
Institutional Review Board.   
 
Preliminary testing 
At least one week before their first experimental trial, participants completed an incremental test 
to exhaustion on a cycle ergometer to determine VO2peak (a marker of cardiorespiratory fitness) 
and maximum heart rate (HRmax).  The protocol for this test included a 4 minute warm-up followed 
by a progressive increase in intensity each minute until voluntary exhaustion (73).  Body 
composition was also assessed using dual energy X-ray absorptiometry (DEXA; Lunar DPX 
DEXA Scanner). 
 
Experimental protocol for each hospital visit 
All subjects were admitted to the Michigan Clinical Research Unit (MCRU) at the University of 
Michigan Hospital a total of five times for metabolic testing throughout the ~3 month participation 
in the entire study (Figure 5-1).  All metabolic studies were identical (Figure 5-2) with the 




The evening before each trial, subjects ingested a standardized meal at 1900h (one-third of total 
daily caloric requirements; 55% carbohydrate, 30% fat, and 15% protein).  The next morning (Day 
1), subjects were provided a standardized breakfast and lunch to be eaten at 0930h at 1230h, 
respectively (see details of all meals provided during the experiments in “Study Diets” section, 
below). At 1600h subjects exercised for 40 minutes at approximately 60% of their pre-determined 
HRmax (~50% VO2peak) on a cycle ergometer.  In order to quantify energy expenditure during 
exercise, we measured VO2 and VCO2 using a metabolic cart (PhysioDyne Technologies) within 
the first and last 10 minutes of the exercise session.  All metabolic studies were identical with the 
exception that subjects did not exercise during visits #1 and #5.  During the two non-exercise visits 
they remained seated quietly during this time. After the exercise period, subjects were allowed to 
shower and they were be provided meals at 1800h and 2000h and an evening snack at 2200h (see 
details in “Study Diets” section, below). One intravenous catheter (IV) was placed in a hand vein 
for blood sampling, and a second IV was be placed in a forearm vein for infusions that began the 
next morning.  During all visits, a urine pregnancy test was performed on all female subjects when 
they arrived on the first day of the experiment.  Other than the supervised exercise session, all 
subjects remained relatively sedentary in the hospital until completion of the trial the next day.  
 
Beginning at 0450h the next morning (Day 2), 3 blood samples were taken in 5 min intervals (i.e.; 
0450h, 0455h, and 0500h) from the heated hand vein to obtain “arterialized” blood samples (44), 
for determination of background enrichment of [6,6 d2]glucose, [1-13C]-palmitate, and [1,1,2,3,3 
d5]-glycerol.  A background sample was also used to determine fasting substrate and hormone 
concentrations as well as markers of systemic inflammation.  At 0500h we began a primed, 
constant rate infusion of [6,6 d2]glucose (35 µmol/kg priming dose; 0.41 µmol/kg/min continuous 
infusion) for measurement of hepatic glucose production and whole-body glucose uptake.  We 
also measured resting metabolic rate (and fat oxidation) for 30 min starting at 0630h using a VMax 
Encore metabolic cart (SensorMedics).  At 0700h we obtain a muscle sample (~100 mg) from the 
vastus lateralis. This muscle sample was cleaned with saline, dried, and then aliquots of this sample 
were quickly frozen in liquid nitrogen.  Samples were stored at -80°C until analysis. In addition, 
we also obtained a 100-200mg subcutaneous adipose tissue sample from the abdominal region.  
Similar to the muscle samples, the adipose tissue biopsy was cleaned with saline, dried, and 
aliquots were quickly frozen in liquid nitrogen. Samples were stored at -80°C until analysis.  At 
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0700 we also began a primed, constant-rate infusion of [1,1,2,3,3 d5]-glycerol (1.5 µmol/kg 
priming dose; 0.10 µmol/kg/min continuous infusion).  Then at 0800h we began a constant-rate 
infusion of [1-13C]-palmitate (0.04 µmol/kg/min continuous infusion).  At 0845h, three arterialized 
blood samples were obtained from a heated hand vein in 5 min intervals for determination of 
glycerol rate of appearance (Ra) in plasma [used as an index of whole body lipolysis], fatty acid 
Ra and fatty acid rate of disappearance (Rd) from plasma [fatty acid mobilization and uptake, 
respectively], as well as determination of basal hepatic glucose production via isotope dilution of 
the constant rate infusion of [6,6 d2]glucose.  These blood samples were analyzed for plasma 
concentrations of glucose and insulin.  At 0900h we began a hyperinsulinemic-euglycemic clamp 
to assess peripheral insulin sensitivity, as described previously by Dr Ralph Defronzo’s laboratory 
(58).  Briefly, the clamp was performed using a primed 2h insulin infusion at a rate of 40 
mU/m2/min.  Plasma glucose concentration was monitored every 5 minutes during the clamp study 
using a glucose auto-analyzer (Yellow Springs Instruments), and glucose (D20 dextrose solution) 
was infused at a variable rate to maintain plasma glucose concentration at participants fasting 
blood glucose concentration (~5 mM).  Importantly, this glucose infusion solution was enriched 
with [6,6 d2]glucose (2.5% enriched) to limit changes in glucose tracer enrichment in plasma (40).  
In addition to the small blood samples collected every ~5 minutes to assess plasma glucose 
concentration, we also collect additional plasma samples for assessment of insulin and plasma 
enrichment of [6,6 d2]glucose during the final 20 min of the 2h clamp.  Subjects also received an 
intravenous infusion of potassium (KCl) during the clamp to prevent hypokalemia.  After 
completing the clamp procedure, subjects were provided a meal, and were monitored until plasma 
glucose concentration was stable.  When vital signs are stable, subjects will be discharged from 
the hospital.   
 
Exercise training program 
Subjects completed a 3-month mild-intensity, exercise training program.   They were required to 








The total energy content of the diet for each hospital stay was estimated to match the energy 
expended.  Energy expenditure on each exercise day while admitted to the hospital was estimated 
as:  {[(VO2 during exercise) x (5kcal/liter of O2 consumed) x 40min] + [597+(26.5 x fat free 
mass)]} (71).  Diets were designed to maintain "energy balance" (i.e.; energy intake = energy 
expenditure) during all trials in order to avoid any confounding influence of a negative energy 
balance on insulin sensitivity (4).  20% of daily energy intake was consumed at 0930h, 1230h, and 
again at 1800h. 30% of total daily energy requirement was provided at 2000h, and 10% of daily 
energy requirement was provided in the evening snack (2200h).  After this snack, subjects did not 
consume anything but water until completion of the clamp procedure the next day.  
 
During the 3-month exercise training program, it was very important to our study design that the 
subjects maintain their body weight.  Subjects were asked to maintain their normal dietary habits, 
they weighed themselves daily and reported their daily body weight to research staff members. We 
also collected a 3 day dietary journal 3 days leading up to Visit #1, after 6 weeks of exercise 
training, and at the end of the 3-month exercise training program.  If body weight changed ±1kg 
during the program, dietary consultation was provided by our research dietitian to help maintain 
their original body weight.  
 
Analytical Procedures  
Plasma substrate and hormone concentrations  
Blood samples were collected in chilled EDTA tubes, centrifuged (1,600 g for 20 min. at 4°C) 
within 30 min of collection, and then stored at -80°C until analysis.  Plasma glucose (glucose 
oxidase assay; Fisher Scientific), fatty acid (NEFA-HR assay kit; WAKO Chemicals USA), 
triacylglyceride (Triacylglyceride reagent; Sigma Adrich), total- and high-density lipoprotein 
(HDL; Cholesterol E and HDL-Cholesterol E; Wako Chemicals USA) concentration were 
measured with commercially available colorimetric assay kits. Plasma insulin concentration was 






Muscle and adipose tissue lysate preparation 
Previously weighed frozen muscle and adipose tissue samples were homogenized in commercially 
available ice cold lysis buffer (Triacylglyceride reagent; Sigma Adrich) supplemented with 
commercially available protease inhibitors (Triacylglyceride reagent; Sigma Adrich) using a 
TissueLyser (Qiagen, Valencia, CA).  Samples were then centrifuged at 1500g for 10 minutes at 
4°C, the upper lipid layer was removed from adipose tissue samples and the supernatant (whole 
cell lysate) collected.  Protein concentration was measured using a commercially available BCA 
protein assay kit (ThermoFisher Scientific, Rockford, IL).  
 
Multiplex analysis 
Skeletal muscle proteins associated with inflammation and insulin resistance (total NFκB, total 
IκBαp, phosphorylated JNK, Aktserine473) were measured using commercially available multiplex 
cell-signaling bead kits (c#:48602, Milliplex MAP Kit, Millipore, Billerica, MA).  Adipose tissue 
and plasma cytokines associated with inflammation (TNF-α , MCP-1, VEGF, IL-6) were measured 
using commercially available multiplex bead kits (c#: HCYTOMAG-60K, Milliplex MAP Kit, 
Millipore, Billerica, MA).  Samples were analyzed using the Luminex L200 instrument (Luminex, 
Austin, TX) and quantifed by xPONENT software (Luminex). 
 
Plasma fatty acid, glycerol, and glucose tracer-tracee ratio (for substrate kinetics calculations)   
The plasma tracer-tracee ratio (TTR) for palmitate, glycerol, and glucose were determined by gas 
chromatography-mass spectrometry (GC/MS) with Mass Selective Detector (Agilent 
Technologies) as previously described (66).  Briefly, starting with 250 µL of plasma and 250 µL 
of internal standard (C17:0), proteins were precipitated from plasma with acetone and lipids 
extracted with hexane.  The hexane fraction was collected and iodomethane was used to convert 
fatty acids to methyl esters (FAMES) that were isolated by solid-phase extraction columns (Sigma 
Aldrich).  Following electron impact ionization, selectively monitoring mass-to-charge ratios of 
ions 74 and 75 were used to determine enrichment of methyl ester palmitate.  Plasma glycerol and 
glucose were isolated from the aqueous portion of the deproteinized sample.  The aqueous fraction 
was dried down and reconstituted in 100 µL of dH20.  A 25 µL aliquot was extracted to create a 
glucose derivative after drying it down, reconstituting it in 2% hydroxylamine in pyridine (50µL) 
followed by a 20 minute incubation at 100°C.  Acetic Anhydride (50 µL) was added to the sample 
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and incubated for 40 minutes at 100°C.  Samples were then diluted in ethyl acetate and stored at -
20°C until GC/MS procedures.  Following electron impact ionization, selectively monitoring 
mass-to-charge ratios of ions 187 and 189 were used to determine enrichment of [6,6 d2] glucose.  
The remaining 75 µL was dried down, reconstituted in pyridine (25 µL) and acetic anhydride (25 
µL), and incubated for 60 minutes at room temperature to create the glycerol derivative.  Following 
electron impact ionization, selectively monitoring mass-to-charge ratios of ions 145 and 148 were 
used to determine enrichment of [1,1,2,3,3 d5]-glycerol.   
 
Intramyocellular glycogen concentration 
Muscle glycogen was determined from measurement of muscle glucose after acid hydrolysis in 
previously weighed and dried muscle samples (65).  Briefly, muscle samples were homogenized 
in dH2O and 2N HCl acid added to neutralize enzymatic activity.  After a 1 hr incubation at 100°C 
samples were neutralized with 1N NaOH to a pH of 6.5-7.5.  Free glucose concentration was 
determined as previously described (65). 
 
Intramyocellular lipid species concentration 
Frozen muscle samples were rapidly homogenized in ice-cold saline and lipids then extracted in a 
single-phase mixture of chloroform-methanol-saline (1:2:0.8) (9) and internal lipid markers for 
IMTG, DAG, and non-esterified fatty acid (NEFA) with fatty acid moieties of odd carbon number 
were added for subsequent purity and recovery determinations (NuChek, Elysian, MN; Avanti 
Polar Lipids, Alabaster, AL). After brief centrifugation, the lower chloroform phase containing 
lipids was transferred to a clean tube and dried under vacuum. 15% ethyl acetate (EtOAc) in 
hexane added to the lipid residue to dissolve diacylglycerol (DAG), triacylglycerol (TAG) and was 
eluted from extraction tube containing 500 mg normal phase silica and was dried down.  Samples 
were again reconstituted in 15% ethyl acetate (EtOAc) in hexane and purified using thin-layer 
chromatography.  Fatty acid methyl esters were generated from purified glycerolipids by alkaline 
methanolysis, a transesterification process as previously described (11), while NEFA 
were converted to methyl esters by a methyl iodide procedure (66).  FAMES were measured by 
gas chromatography and electron-impact mass spectrometry (Agilent 6890A GC and 5973N MSD, 
Palo Alto, CA).  Following electron impact ionization, selectively monitoring mass-to-charge 
ratios of ions 74, 79 and molecular ions) at retention times for individual FAMES, and quantified 
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using FAME standards (NuChek, Elysian, MN). A complete description of the muscle lipid 
analysis can be found in APPENDIX 3.   
 
Western blotting  
Previously weighed frozen muscle samples were homogenized in commercially available ice cold 
lysis buffer (Triacylglyceride reagent; Sigma Adrich) supplemented with commercially available 
protease inhibitors (Triacylglyceride reagent; Sigma Adrich), centrifuged at 1500g for 10 minutes 
at 4°C, and the supernatant (whole cell lysate) collected for protein concentration and western 
blotting analysis.  SDS-page was used to separate 20µg of sample that was transferred to a 
nitrocellulose membrane.  Blots were probed with the following antibodies: pIRS-1 Ser312 (catalog 
#: 2381S; Cell Signaling Technology), Complex-1 (catalog #: 459100; Invitrogen), CPT-1 (catalog 
#: sc20514; Santa Cruz Biotechnology), CD36 (catalog #: sc9154; Santra Cruz Biotechnology), 
GPAT (a gift from RA Colemen), DGAT-1 novus (catalog #: NB110-41487; Novus Biologicals), 
and DGAT-2 (catalog #: sc66859; Santa Cruz Biotechnology).  Nitrocellulose membranes were 
incubated in species specific secondary antibodies, developed with enhanced chemiluminescence 
(Amersham Biosciences), and quantified by densitometry (Alpha Ease FC, Alpha Innotech Corp.).  
Within subject comparisons were prepared on the same blot.   
 
Calculations 
Indices of Insulin Sensitivity: Plasma glucose and insulin concentrations measured before and 
during the meal tolerance test were used to assess whole body insulin sensitivity using the Matsuda 
Composite Index and hepatic insulin resistance as previously described (2).   
  
Matsuda Composite Index = 10000/√[(fasting Insulin x fasting glucose) x (2h Insulin x 2h 
glucose)] 
 
Hepatic Insulin Sensitivity Index = [Glucose AUC0-30] x [Insulin AUC0-30]  
 
Hepatic glucose production (HGP). Basal HGP (before the hyperinsulinemic-euglycemic clamp) 
was calculated using the equation of Steele for steady-state conditions [HGPbasal = Glucose Ra = 
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([d2]-glucose infusion rate)/TTR] (82).  During the hyperinsulinemic-euglycemic clamp, total 
glucose Ra was calculated using the Steele equation (82) from samples collected during the steady-
state period of the clamp (i.e., last 20 min).  HGP during the clamp was calculated as the difference 
between Glucose Ra during the clamp and exogenous glucose infusion rate (GIR) used to maintain 
euglycemia during the steady state period of the clamp (HGPclamp = Glucose Ra – GIR).  
 
Rate of glucose disappearance from plasma (Glucose Rd).  Under basal conditions (before the 
hyperinsulinemic-euglycemic clamp), Glucose Rdbasal = Glucose Rabasal (or HGPbasal), so Glucose 
Rdbasal was also be calculated using the Steele equation for steady state conditions (82).  During 
the clamp, steady-state Glucose Rd was calculated using the Steele equation (82) from samples 
collected during the steady-state period of the clamp (i.e., last 20 min).    
 
Insulin sensitivity. Hepatic insulin sensitivity was calculated as the insulin-induced percent 
suppression of endogenous glucose production.  
 
Hepatic insulin sensitivity = [1-(HGPclamp/HGPbasal)] x 100% 
 
Peripheral insulin sensitivity was calculated as the total rate of glucose uptake during the steady 
state portion of the clamp (Glucose Rdclamp), normalized to the steady-state insulin concentration 
during the clamp (steady-state insulinclamp). 
 
Peripheral insulin sensitivity = Glucose Rdclamp/(steady-state insulinclamp) 
 
Rate of fat oxidation: Whole body fat/triacylglycerol oxidation (g/min) was calculated from VO2 
and VCO2 measurements using the equations of Frayn (29).  Whole body fatty acid oxidation was 
calculated by dividing triacylglycerol oxidation by an estimated molecular weight of 
triacylglycerol (860 g/mol) and multiplying by 3.   
 
Glycerol and fatty acid kinetics. We used the Steele equation for steady-state conditions (82) to 
calculate both glycerol Ra (assessment of whole-body lipolysis) and palmitate Ra (assessment of 
fatty acid mobilization into plasma).  Because our measurements was performed under steady-
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state conditions, palmitate Ra = palmitate Rd, which provides an assessment of systemic fatty acid 
uptake. We also estimated total fatty acid Ra (and Rd) by dividing palmitate Ra (and Rd) by the 
ratio of plasma palmitate to total plasma fatty acid concentration.  Fatty acid and glycerol kinetics 
were only measured in the basal state (i.e., non-insulin stimulated conditions) 
 
Low-density lipoprotein cholesterol (LDL-C). LDL-C was calculated from measurements of 
plasma concentrations of total cholesterol (Total-C),  HDL-C, and triacylglyceride (i.e., [LDL-C] 
= ([Total-C] – [HDL-C] – [Triacylglyceride])/5  (60)) 
 
Statistical analysis 
Linear mixed model with time as a categorical factor was used to determine differences in outcome 
variables compared with measurements made before the exercise program (“PRE”).   
Statistical significance was defined as P ≤ 0.05. 
 
Results 
Compliance, fitness, and body composition responses to exercise training 
Adherence to the prescribed exercise training program was very high.  Subjects completed 99±2% 
of all exercise sessions during the first two weeks and 92±2% of all exercise sessions throughout 
the remaining 10 weeks of the exercise training program (see Appendix 3).   Despite this very high 
compliance, our low-intensity exercise training program did not significantly increase VO2max 
(Table 5-1, P=0.14) and our markers of mitochondrial density in skeletal muscle (i.e., complex-1 
and carnitine palmitoyl transferase-1 [CPT-I]) were also not affected (data not shown).  As 
designed, body weight and fat mass remained very stable throughout the 3-month exercise program 
(Table 5-1).  This successful control of body weight and body composition allows for interpretation 
of these findings to focus specifically on the effects of the mild exercise training program.   
 
Measures of insulin sensitivity 
Meal tolerance test performed in the few hours after exercise. On Day 1 of each experimental trial 
we estimated whole-body insulin sensitivity index (ISI) using the Matsuda composite index during 
a meal tolerance test that began 80 minutes after completion of exercise (or rest during Visit #1 
and #5). A single session of exercise did not affect ISI, but ISI was modestly, yet significantly 
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improved after 2 weeks of the exercise program (Figure 5-3A; P=0.02).  This improvement in 
whole-body ISI at 2 weeks was accompanied by a significant reduction in hepatic insulin resistance 
(Figure 5-3B; P=0.03), as assessed by calculations previously established by Abdul-Ghani, et al., 
(2). ISI did not improve any further after 3 months of the exercise program (Figure 5-3A).   
 
Hyperinsulinemic-euglycemic clamp performed the day after exercise.  To assess more persistent 
effects of exercise on insulin sensitivity (i.e., into the next day), a hyperinsulinemic-euglycemic 
clamp was performed ~16h after exercise.  We found insulin sensitivity to be largely unaffected 
the day after 1 exercise session or even after 2 weeks of exercise (Figure 5-4A).  We did observe 
a trend for an improvement in insulin sensitivity after 3-months of this low-intensity exercise 
training program, but this did not quite reach statistical significance (Glucose Rd/SSI: 2.4±0.3 vs. 
2.9±0.3 (mg/min)/[SSI]; P=0.065). This trend for improved insulin sensitivity at the end of the 3-
month training program disappeared when the subjects abstained from exercise for 3 days (Figure 
5-4). Similar to the trend for improved insulin sensitivity after 3 months of training, GLUT4 
protein abundance also tended (P=0.10) to be elevated at this time, and this trend persisted even 
after the subjects did not exercise for 3 days. (Figure 5-4 C).  Hepatic insulin resistance was 
remarkably stable after 1 session, 2 weeks, and 3 months of training (Figure 5-4B). 
 
Skeletal muscle inflammation and markers of insulin signaling  
In agreement with our finding that the exercise program did not robustly improve insulin action, 
markers of pro-inflammatory signaling in skeletal muscle, NFκB, IκBα, and pJNK were also 
unchanged after 1 session, 2 weeks or 3 months of the exercise training program (Table 5-2). 
Similarly, we did not find any changes in the phosphorylation state of AktSer473 or IRS-1Ser312  
(Table 5-3), which have been identified as being crude markers of insulin signaling in non-insulin 
stimulated tissue (17, 53)  
 
Skeletal muscle glycogen and lipid content 
Muscle glycogen concentration did not change significantly throughout the 3 month training 
period (Figure 5-5A).  Similarly, neither IMTG nor intramyocellular DAG content were 
significantly affected the day after 1 session, 2 weeks, and even after 3 months of this mild exercise 
training program (Figure 5-5 B-C), but there was a considerable degree of variability in these 
101 
 
muscle lipid measures.  Abundance of key enzymes involved in IMTG synthesis (i.e., GPAT, 
DGAT1, and DGAT2) were also unchanged during the 3 month exercise training program (Table 
5-4).  
 
Changes in substrate oxidation and fatty acid uptake 
The mild exercise training program did induce some changes in fuel selection both during exercise 
and at rest.  Compared with fat oxidation measured during the very first exercise training session, 
3 months of training significantly increased the mean exercise fatty acid oxidation from 8.6±1.3 
to 11.8±1.7 µmol/kgFFM/min (P<0.01).  Additionally, compared with before starting the training 
program, 2 weeks of exercise training increased resting fatty acid oxidation and it remained 
elevated after 3 months of exercise training (Figure 5-6 A). Accompanying this increase in resting 
fatty acid oxidation, we found a strong trend (P=0.12) for an increase in fatty acid Rd (i.e., fatty 
acid uptake) starting at two weeks of the training program (Figure 5-6 B).  This was also 
accompanied by a significant increase in skeletal muscle abundance of the fatty acid transporter 
FAT/CD36 after 3 months of exercise training (Figure 5-6 C).  However, as noted above, we did 
not find changes in mitochondrial fatty acid transport protein CPT-1 (data not shown). Lipolytic 
rate (i.e., glycerol Ra) and re-esterification remained largely unaffected by the exercise training 
program (Table 5-5). We found a slight increase in fasting plasma fatty acid concentration after 2 
weeks and 3 months of training (Table 5-6), which likely reflected an increase in lipolytic rate 
during exercise during the previous evening.  
 
Blood lipid concentrations 
The exercise program induced a progressive reduction in plasma total cholesterol (Total-C), which 
reached statistical significance after 3 months of training (Table 5-6, P<0.01).  This reduction in 
Total-C was due to a reduction in low-density lipoprotein cholesterol (Table 5-6, P<0.01).   The 
exercise program did not alter fasting triglyceride concentration (Table 5-6).  
 
Markers of adipose tissue and systemic inflammation 
Three months of low-intensity exercise training did not influence markers of adipose tissue 
inflammation including TNF-α, MCP-1, and VEGF (Table 5-7).  Additionally systemic pro-
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inflammatory proteins including IL-6, TNF-α, and MCP-1 did not change throughout the 3 month 
mild exercise training program (Table 5-8).   
 
Discussion 
Epidemiological evidence clearly indicates that even a rather modest increase in regular physical 
activity behavior in formerly sedentary adults can profoundly reduce disease risk and all cause 
mortality (12, 85).  Yet the time course for physiological adaptations, and resultant changes in 
markers of cardiometabolic health during the early stages of adopting a physically active lifestyle 
are not clearly understood.  Our major findings indicate that a single session of low-intensity 
exercise (i.e., the very first exercise training session) was not enough of a stimulus to improve 
insulin sensitivity, but our measures of whole-body insulin sensitivity and hepatic insulin 
resistance were improved after two weeks of the exercise program.  The insulin sensitizing effects 
of exercise were relatively short-lived, as evidenced by improvements in insulin sensitivity when 
measured in the few hours after exercise but not the next morning.  These improvements in insulin 
sensitivity within the few hours after exercise were maintained, but not enhanced further with an 
additional 10 weeks of exercise training.  We also found that 3 months of low-intensity exercise 
training induced clinically meaningful improvements in the blood lipid profile of our obese 
subjects.  Importantly, the beneficial health effects of exercise in this study could not be attributed 
to changes in body weight or body composition because these remained unchanged throughout the 
3-month exercise program.   
 
The precise mechanisms responsible for the improvement in the insulin sensitivity index (ISI) 
measured a few hours after exercise are not clear, but improvement in hepatic insulin resistance 
may be an important contributor to this effect – at least in the short-term.  This is based on our 
observation that enhanced whole-body ISI after two weeks of the exercise program was 
accompanied by an improvement in our assessment of hepatic insulin resistance.  Our finding that 
hepatic insulin resistance improved ~15% after 2 weeks of the exercise program, was similar to 
the improvement found in comparable cohort of obese subjects after 7 days of a more intense 
exercise training program (i.e., 1h of exercise at 85% HRmax for 7 consecutive days) (48).  How 
the cumulative effects of a few sessions of exercise (without weight loss) may alter insulin action 
in the liver remains unclear.  It has been suggested that regular exercise may lower or prevent 
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accumulation of lipid within the liver by suppressing lipogenic potential during the exercise 
session, as well as during the first few hours after exercise (45).  Indeed seven continuous days of 
exercise training has been found to lower hepatic triglyceride content in obese adults with non-
alcoholic fatty liver disease (36).  Because hepatic lipid accumulation can negatively impact 
hepatic insulin action (16, 50, 80), perhaps even just a few days of exercise may be enough to 
induce a subtle, yet physiologically meaningful reduction in lipid accumulation in the liver that 
may translate to an improvement in hepatic insulin sensitivity.  Interestingly, although the 
improvement in whole-body ISI was maintained throughout the next 10 weeks of our exercise 
program, the improvement in hepatic insulin resistance appeared to largely reverse.  The reason 
why the improvement in hepatic insulin resistance may dissipate as the exercise program continued 
is puzzling, but if true, this suggests that the persistent improvement in whole-body ISI after 3 
months was a consequence of a shift from improved hepatic insulin sensitivity in the early stages 
of the exercise program to enhanced peripheral insulin action.   
 
Exercise training is often reported to improve insulin sensitivity in obese adults when measured 
several hours or even a few days after the most recent session of exercise (6, 20, 25, 27, 35, 41, 
84).  Unfortunately, many studies that examine the effects of exercise training on insulin sensitivity 
in obese adults do not strictly control body weight during the exercise program (6, 25, 41), making 
it impossible to differentiate the effects of the exercise training from the potent effects of weight 
loss.  However, some studies designed to prevent changes in body weight during the training 
program have reported a persistent improvement in insulin sensitivity with exercise training 
without weight loss (27, 84), but this finding is not universal (28, 78).  Findings from PROJECT 
#2 of my dissertation support the notion that exercise training in overweight adults may indeed 
induce adaptations resulting in a persistent improvement in insulin sensitivity (see Chapter 4).  In 
contrast, in the present study we did not find a persistent improvement in insulin sensitivity after 
3 months of training, especially when measured 3 days after the most recent session of exercise.  
Perhaps this discrepancy can be explained by the relatively low exercise stimulus used in our 
present study, which may have been insufficient to induce persistent effects on insulin action.  
Interestingly, we did find a strong trend for enhanced insulin sensitivity measured 16 hours after 
the last exercise training session of the 3 month exercise program.  This modest improvement was 
largely driven by 6 out of our 9 participants, and these subjects increased their insulin sensitivity 
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by 15-57%.  We acknowledge that the relatively small sample size likely contributed to our 
inability to detect a significant improvement in insulin sensitivity at 3 months when measured the 
day after the last session of exercise.  However, it is also apparent that the insulin sensitizing effect 
in response to our 3-month mild exercise training program was not tremendously robust, and again, 
this trend was clearly no longer apparent when subjects abstained from exercise for 3 days after 
the 3 month training program. 
 
In contrast to many previous studies (21, 22, 57, 67), including some from our laboratory (61, 73), 
insulin sensitivity in this study was not improved after a single session of exercise (i.e., after the 
first exercise training session).  This finding is also somewhat in contrast to findings from 
PROJECT #2 of my dissertation in which a single exercise session did enhance insulin sensitivity 
the next day in a cohort of sedentary overweight adults.  An explanation for this discrepancy may 
be very similar to our rationale for the lack of robust adaptations to the exercise training program; 
it is likely that the absence of an insulin sensitizing effect of a single session of exercise in the 
present study may have been a consequence of our rather low exercise stimulus.  Therefore, this 
suggests that the exercise “dose” used in this study may have been below some threshold required 
to enhance insulin action, even in people who do not exercise regularly.   Findings from this study, 
together with findings from one of our very recent studies (61) may help us better identify the 
magnitude of an exercise “dose” necessary to induce a persistent improvement in insulin action - 
at least sustained into the next day.  We very recently reported that expending 350 kcals during a 
single 70 minute session of exercise at 50% VO2max improved insulin sensitivity the next morning 
in a very similar obese cohort as in the present study (61).  However, in the current study we found 
that 40 minutes of exercise at 60%HRmax (i.e., equivalent to ~50% VO2max and energy 
expenditure <200kcal) was not sufficient to improve measures of insulin sensitivity the next day.  
Obviously, these findings suggest that a minimum “dose” of mild intensity exercise (i.e., ~50% 
VO2max) is somewhere between 40 to 70 min of exercise.  It may be quite logical to conclude that 
the amount of energy expended during the exercise session would be a key element determining 
the “threshold” for enhancing insulin action, but we cannot rule out the possibility that the duration 
of exercise may be an important factor, independently of the energy expended.  This is based on 
our earlier finding that expending 350 kcals while exercising at 50% VO2max (i.e., ~70 min of 
exercise) significantly enhanced insulin sensitivity the next morning, but expending 350kcals 
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while exercising at 65% VO2max (i.e., ~50 min of exercise) did not (61), suggesting that the 
duration of exercise may influence this effect.  Although perhaps somewhat counter-intuitive, 
these findings are consistent with other studies suggesting that lower intensity but longer duration 
exercise may be better at improving insulin sensitivity and blood glucose control in individuals 
with type 2 diabetes (6, 54).   
 
There has been considerable debate about the role of oxidative capacity on the regulation of insulin 
resistance (64, 73, 75, 83).  In particular, much of this debate has centered around the role that 
increased fatty acid oxidation may have on reducing the accumulation of intramyocellular lipids 
known to impair insulin signaling (64, 73, 75, 83).  Several reports have suggested that 
impairments in mitochondrial function and a resultant suppression in fatty acid oxidative capacity 
are important underlying factors for the development of insulin resistance (8, 51, 68).  It has been 
suggested that by increasing oxidative capacity via exercise training, this could relieve the lipid-
induced insulin resistance commonly found in obesity (24, 30, 69).  In contrast, fatty acid oxidation 
is often not found to be low in adults with a moderate degree of obesity (BMI: 30-40kg/m2) (7, 38, 
43), and a high capacity to oxidize fatty acids does not necessarily protect against insulin resistance 
(55, 59, 73).  In support of these latter findings, we found that although fatty acid oxidation was 
augmented by the exercise training program, this was not accompanied by a reduction in 
intramyocellular lipid concentration, and did not coincide with enhanced insulin action measured 
the day after exercise.  Our data also indicate that mild exercise training without weight loss did 
not suppress lipolysis or fatty acid mobilization, which is in agreement with previous reports 
showing that exercise training does not reduce systemic fatty acid availability in weight-stable 
obese adults (37, 39).  Therefore, although the contribution of a low oxidative capacity on muscle 
lipid accumulation and insulin sensitivity remains to be resolved, exercise training (in the absence 
of weight loss) does not appear to relieve the persistent physiologic stress of excessive systemic 
fatty acid overabundance in obese adults. 
 
Systemic and tissue-specific inflammatory stress are considered key factors underlying the 
increased disease risk in obesity (34, 62, 76), and may play particularly important roles in the 
development of insulin resistance (62, 76).  However, whether changes in systemic, adipose tissue, 
and/or skeletal muscle inflammation contribute to the exercise-induced reduction in 
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cardiometabolic disease risk has not been resolved.  Adipose tissue expansion and the resultant 
elevated fatty acid availability that occur with weight gain and the development of obesity are 
primary contributors to pro-inflammatory macrophage accumulation within adipose tissue (49, 86) 
and release of pro-inflammatory cytokines into the systemic circulation.  In turn, weight loss 
reverses this macrophage infiltration in adipose tissue (49) as well as markedly suppresses the 
abundance of systemic pro-inflammatory cytokines (14, 15, 18).  In animal models, both acute 
exercise (63) and exercise training have been reported to reduce pro-inflammatory macrophage 
infiltration in adipose tissue and lower cytokine expression (47).  However, studies in human 
subjects have reported that neither acute exercise (19, 56, 77) nor exercise training reduced 
concentration of pro-inflammatory cytokines in obese weight-stable adults (3, 18).  Our data 
support findings from Christiansen, et al, (18) in that neither markers of inflammation in the 
systemic circulation (i.e., IL-6, TNF-α, and MCP-1) nor adipose tissue (i.e., TNF-α, MCP-1, and 
VEGF) were reduced by the end of the 3-month exercise program.  These findings suggest that in 
absence of weight loss, low-intensity exercise training, per se, may not affect adipose tissue or 
systemic inflammation.  The influence of exercise on inflammatory pathway activation in skeletal 
muscle is also complex.  A previous study from our lab clearly demonstrated that weight loss 
(without exercise) suppressed markers of inflammatory signaling in skeletal muscle, yet when 
exercise training was added to the weight loss program, skeletal muscle inflammation was not 
reduced any further (73).  Therefore, findings from our present study indicating that mild exercise 
training did not influence skeletal muscle pro-inflammatory stress including NFκB, IκBα, and 
pJNK, are in line with our previous work (73).  Much like our conclusions about systemic and 
adipose tissue inflammation, these findings suggesting that in the absence of weight loss, exercise 
training (at least rather mild exercise training) may not affect some important inflammatory 
pathways in skeletal muscle. 
 
We did find that 3-months of mild exercise training without weight loss improved blood lipid 
profile of our obese participants.  Despite the accelerated interest and development of 
pharmacological treatments for hypercholesterolemia (5, 46), exercise remains a mainstay in the 
therapeutic approach for improving blood lipid profile.  Because higher cardiorespiratory fitness 
(e.g., VO2max) is associated with lower cardiovascular disease risk (52) and higher intensity 
exercise training is often required to induce robust improvements in VO2max (26), vigorous 
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exercise is often recommend for improving cardiovascular disease risk factors, like lowering blood 
lipids.  However, our mild intensity exercise program lowered plasma LDL cholesterol, which 
resulted in a reduction in total cholesterol, without improving VO2max.  How our exercise 
program lowered plasma LDL-C is not clear.  Because triglyceride rich very low-density 
lipoprotein (VLDL) is a precursor for LDL, a reduction in VLDL could lower LDL.  Although we 
did not measure VLDL and we did not see changes in plasma triglyceride concentration, previous 
reports have indicated that exercise training can lower plasma VLDL concentration (79, 81).  
Regardless of the mechanism(s) responsible for lowering LDL-C and Total-C, these changes 
represent clinically relevant adaptations in response to rather mild exercise, even without weight 
loss.  More specifically we found an 11% reduction in Total-C, which associated with a reduction 
in relative risk for all-cause mortality by as much as 13% (32, 33).  We also found that LDL-C 
was reduced by ~21 mg/dl, which is well above estimates suggesting that an 11 mg/dl reduction 
in LDL-C translates to a 9.2% reduction in relative risk for all-cause mortality (31).   
 
The overarching goal of this study was to determine the progressive adaptations associated with 
adopting a mild exercise training program in weight-stable obese adults.  We found that a single 
40 minute session of low-intensity exercise was not sufficient to improve insulin sensitivity or 
reduce other cardiometabolic disease risk factors.  However, improvements in insulin sensitivity 
were apparent after 2 weeks of mild exercise training, but this improvement was very short-lived; 
measurable improvement in the few hours after exercise, but did not extend into the next day.  
Importantly, even a relatively short-lived enhancement of insulin action (for the few hours after 
exercise) may still have profound long-term metabolic health benefits, but to truly reap these 
metabolic benefits the exercise would need to be performed very regularly (i.e., daily).  We also 
found improvements in blood lipid profile after 3 months of exercise training, even in the absence 
of weight loss.  Although the mechanisms responsible for improvements in cardiometabolic health 
in response to a mild exercise intervention are not completely understood, these effects may 
represent a compilation of relatively subtle adaptations in multiple tissues, such as skeletal muscle, 




 Table 5-1. Participant characteristics before and after the 3-month exercise training 
program 
 Before After 
Sex (M/F) (3/9) ̶ 
Age (y) 29.5 ± 2.5 ̶ 
Body weight (kg) 108.2 ± 4.3 108.7 ± 4.7 
BMI (kg/m2) 37.6 ± 1.4 38.1 ± 1.5 
Body fat (%) 47.5 ± 2.2 47.7 ± 2.5 
Fat mass (kg) 51.6 ± 3.4 52.0 ± 3.8 
Fat free mass (kg) 56.6 ± 3.0 56.7 ± 3.3 
VO2max (L/min) 1.9 ± 0.1 1.9 ± 0.2 















3d after EX 
(n=8) 
NFκB (AU) 494 ± 60 664 ± 106 475 ± 73 418 ± 132 526 ± 63 
IκBα (AU) 529 ± 120 561 ± 142 502 ± 124 617 ± 227 731 ± 72 
pJNK (AU) 55 ± 13 81 ± 16 51 ± 12 87 ± 25 64 ± 17 
Values are expressed mean ± SE. PRE: before starting the exercise program; 1EX: the day 
after the first exercise training session; 2WKS: the day after the 12th exercise session (2 
weeks of the exercise program); 3M: the day after the last exercise session at 3 months of 
the program; 3d after EX: exactly 3 days after the last exercise session after 3 months of 
the exercise program. NFκB, Neclear Factor Kappa-B; IκBα, inhibitor of NFκB; pJNK, 














3d after EX 
(n=8) 
pAkt s473 (AU) 6.1 ± 0.7 6.1 ± 0.5 5.6 ± 0.5 7.3 ± 0.8 7.5 ± 0.7 
pIRS-1 s312 (AU) 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0 
Values are expressed mean ± SE. PRE: before starting the exercise program; 1EX: the day 
after the first exercise training session; 2WKS: the day after the 12th exercise session (2 weeks 
of the exercise program); 3M: the day after the last exercise session at 3 months of the 
program; 3d after EX: exactly 3 days after the last exercise session after 3 months of the 
exercise program.  pAkt s473, phosphorylation of protein kinase-B serine residue 473; pIRS-1 















3d after EX 
(n=8) 
GPAT (AU) 6.1 ± 0.7 6.1 ± 0.5 5.6 ± 0.5 7.3 ± 0.8 7.5 ± 0.7 
DGAT1 (AU) 9.3 ± 1.1 9.4 ± 0.6 11.1 ± 0.6 10.0 ± 0.5 9.3 ± 1.0 
DGAT2 (AU) 2.2 ± 0.1 2.2 ± 0.1 2.3 ± 0.1 2.3 ±0.1 2.3 ± 0.1 
Values are expressed mean ± SE. PRE: before starting the exercise program; 1EX: the 
day after the first exercise training session; 2WKS: the day after the 12th exercise session 
(2 weeks of the exercise program); 3M: the day after the last exercise session at 3 months 
of the program; 3d after EX: exactly 3 days after the last exercise session after 3 months 
of the exercise program.  GPAT, glycerol-3-phosphate; DGAT1 diglyceride 

















3d after EX 
(n=8) 
Glycerol Ra (µmol/min) 340 ± 49 302 ± 33 354 ± 49 361 ± 47 323 ± 37 
Glycerol Re-esterification (%) 49 ± 4% 50 ± 3% 49 ± 3% 52 ± 6% 48 ± 4% 
Values are expressed mean ± SE. PRE: before starting the exercise program; 1EX: the day after 
the first exercise training session; 2WKS: the day after the 12th exercise session (2 weeks of the 
exercise program); 3M: the day after the last exercise session at 3 months of the program; 3d 
















3d after EX 
(n=8) 
Glucose mmol/L 4.8 ± 0.1 4.6 ± 0.1 4.5 ± 0.2 4.6 ± 0.1 4.6 ± 0.1 
Insulin uU/mL 27.1 ± 1.4 29.4 ± 1.5 29.4 ± 1.3 27.1 ± 2.3 26.2 ± 2.8 
Triglyceride mg/dL 110.9 ± 20.9 115.8 ± 19.3 116.8 ± 24.6 122.3 ± 28.4 114.8 ± 22.1 
Total-C mg/dL 184.0 ± 10.5 174.4 ± 9.6 176.2 ± 8.7 174.8 ± 8.3 163.1 ± 6.6* 
LDL-C mg/dL 152.3 ± 11.0 142.7 ± 10.0 144.3 ± 10.0 142.1 ± 11.2 131.3 ± 9.1* 
HDL-C mg/dL 31.7 ± 2.8 31.7 ± 2.9 31.9 ± 2.7 32.5 ± 3.6 31.5 ± 3.9 
NEFA µmol/mL 0.39 ± 0.03 0.36 ± 0.03 0.48 ± 0.04* 0.50 ± 0.05* 0.38 ± 0.04 
Values are expressed mean ± SE. PRE: before starting the exercise program; 1EX: the day after 
the first exercise training session; 2WKS: the day after the 12th exercise session (2 weeks of the 
exercise program); 3M: the day after the last exercise session at 3 months of the program; 3d 
after EX: exactly 3 days after the last exercise session after 3 months of the exercise program.  
* Significantly different than PRE, P < 0.05.  Total-C, total cholesterol; LDL-C, low-density 

















3d after EX 
(n=8) 
TNF-α (pg/µg protein) 0.06 ± 0.02 0.05 ± 0.01 0.09 ± 0.05 0.05 ± 0.01 0.05 ± 0.01 
MCP-1 (pg/µg protein) 1.6 ± 0.4 1.2 ± 0.2 1.5 ± 0.2 1.3 ± 0.1 1.7 ± 0.4 
VEGF (pg/µg protein) 7.6 ± 1.3 7.3 ± 1.4 6.0 ± 0.7 5.7 ± 0.8 7.7 ± 1.5 
Values are expressed mean ± SE.  PRE: before starting the exercise program; 1EX: the day after 
the first exercise training session; 2WKS: the day after the 12th exercise session (2 weeks of the 
exercise program); 3M: the day after the last exercise session at 3 months of the program; 3d after 
EX: exactly 3 days after the last exercise session after 3 months of the exercise program.  TNF-α, 
tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant protein-1, VEGF, vascular 















3d after EX 
(n=8) 
IL-6 (pg/mL) 5.1 ± 1.6 4.7 ± 2.2 4.6 ± 2.1 5.0 ± 1.7 4.3 ± 1.9 
TNF-α (pg/mL) 6.5 ± 0.8 6.7 ± 1.0 6.8 ± 0.8 6.9 ± 1.0 5.9 ± 0.8 
MCP-1 (pg/mL) 202.4 ± 27.3 178.1 ± 23.0 187.8 ± 21.1 187.3 ± 21.5 163.0 ± 11.5 
Values are expressed mean ± SE. PRE: before starting the exercise program; 1EX: the day after 
the first exercise training session; 2WKS: the day after the 12th exercise session (2 weeks of the 
exercise program); 3M: the day after the last exercise session at 3 months of the program; 3d 
after EX: exactly 3 days after the last exercise session after 3 months of the exercise program.  
IL-6, Interleukin-6; TNF-α, tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant 
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A physically active lifestyle is clearly linked with enhanced cardiometabolic health, yet it is very 
surprising that there are still many unresolved questions about how physical activity/exercise 
improves important health outcomes.  For example, although exercise does not need to be 
particularly vigorous in order to reduce cardiometabolic disease risk, it remains unclear how 
relatively mild exercise induces important health benefits, even when the exercise stimulus is 
below the level often found to be required to induce adaptations classically associated with 
improved VO2max.  The physiological adaptations stemming from a moderate increase in habitual 
physical activity behavior and the time course for these adaptations that occur in the early stages 
of adopting a more physically active lifestyle have not been clearly characterized.  Additionally, 
beneficial metabolic responses in the few to several hours after each exercise session suggests that 
the transient acute response to exercise might be even more important than adaptations accrued 
from weeks, months or even years of exercise.  However, a clear dissociation between the 
contributions of transient acute responses to exercise and the more chronic adaptations accrued 
from a habitual exercise routine on the exercise-induced reduction of cardiometabolic risk factors 
has not been fully discerned.  Collectively my dissertation projects were designed to distinguish 
between the health benefits derived from acute exercise compared to habitual physical 
activity/exercise in overweight and obese adults, as well as examined the time course of some key 
metabolic adaptations that occur as a consequence of an increase in habitual physical activity. 
 
Together the three projects of my dissertation enhanced our understanding of health benefits and 
underlying mechanisms resulting from acute and habitual physical activity/exercise.  Important 
findings from my dissertation studies include: 1) in a large population study, I established that the 
degree of physical activity was significantly associated with lower insulin resistance, but VO2max 
was not (PROJECT #1), 2) affirmed that key health benefits can be derived from exercise 
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independently from of any improvement in VO2max (PROJECT #1 and PROJECT #3), 3) 
demonstrated that reductions in systemic pro-inflammatory stress after a single session of exercise 
may contribute to the exercise-induced improvements in insulin sensitivity (PROJECT #2), 4) 
discovered that a single session of exercise at 50%VO2max for 40 min may be below a “threshold” 
for exercise stimulus required to induce a persistent improvement in insulin sensitivity into the 
next day in obese adults (PROJECT #3), and 5)  3 months of a low-intensity exercise training 
without weight loss did not alter markers of pro-inflammatory stress or induce persistent 
improvements in insulin sensitivity among overweight and obese adults.  In the discussion that 
follows, I will focus primarily on the collective and integrative implications of these findings. 
 
A key tenet of my dissertation centered on the important health benefits stemming from a single 
session of exercise.  Given the well-established impact that acute exercise has on key health 
outcomes, (like insulin resistance) and that many of the health benefits of exercise training “wear 
off” after even a few days without exercise, it seems logical to develop exercise prescriptions that 
focus on optimizing the acute responses to EACH exercise session.  However, practical issues like 
“how much” of an exercise stimulus is required for improvement and does this exercise 
requirement change as the individual adapts to a routine exercise regimen, remain unresolved.  In 
PROJECT #2, I found that a single session of moderate-intensity exercise (~60% VO2max for 1 
h) was sufficient to improve insulin sensitivity the next day in overweight/obese sedentary 
subjects.  In contrast, in PROJECT #3, when a similar cohort of sedentary obese subjects were 
exposed to a lower exercise stimulus (50% VO2max for 40 min) insulin sensitivity was not 
improved the next day.  It may be important to acknowledge that the methods used to assess insulin 
sensitivity the day after exercise were different in these two studies.  But the hyperinsulinemic-
euglcemic clamp was used in PROJECT #3 (i.e., the “gold standard” for assessing insulin 
sensitivity), and this relatively sensitive method still did not detect improvement in insulin action 
the day after the mild exercise session.  The findings here suggest that the exercise “dose” of about 
40 min of exercise at 50%VO2max used in PROJECT #3 may be below a minimum threshold 
necessary to enhance insulin sensitivity into the next day in this population of obese sedentary 
adults.  In another very recent study from our lab (1), we found that a single 70 minute session of 
exercise at 50% VO2max improved insulin sensitivity the next morning, again, using the clamp 
procedure, in a very similar obese cohort as in the present study.  Together these findings suggest 
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that a minimum “dose” of mild intensity exercise (i.e., ~50% VO2max) is somewhere between 40 
to 70 min of exercise.  It is certainly tempting to propose follow-up exercise “dose-response” 
studies in an attempt to more precisely identify the dose of exercise necessary to induce a persistent 
improvement in insulin sensitivity (at least into the next day).  However, because multiple 
components contribute to defining an exercise “dose” (e.g., intensity, duration, mode, energy 
expenditure), and other complexities such as meal timing and content, as well as inter-individual 
variability will greatly complicate matters, trying to achieve high precision would be very 
challenging. 
 
Unlike the insulin sensitizing effects of acute exercise in overweight subjects who do not normally 
exercise, in PROJECT #2 I also found that a single session of moderate exercise did not increase 
insulin sensitivity the next day in overweight adults who already exercise regularly.  The 
underlying reason for this is not clear, but may be related to less muscle glycogen used during 
exercise after training, which in turn may attenuate the exercise-induced enhancement of insulin 
sensitivity.  Other training adaptations (e.g., changes in blood flow regulation to the active muscle, 
increased mitochondrial density) that result is a lower metabolic stress during the exercise session 
may also contribute to this phenomenon.  From a practical perspective, this quite simply suggests 
that as a person advances in an exercise program, the exercise stimulus may need to increase 
progressively in order to reap some/much/all of the health benefits of the acute exercise session.  
This has important clinical implications, and it may be beneficial for exercise/lifestyle 
prescriptions to incorporate a recommendation to progressively increase exercise intensity. 
 
Although the improvement in VO2max that often accompanies long-term moderate-to-vigorous 
exercise training is commonly credited for improvements in health, it is not clear that the 
physiologic adaptations in skeletal muscle (i.e., increased mitochondrial and capillary density) 
contributing to the improvement in VO2max are necessary for the reduction in disease risk factors 
often found with exercise training.  In PROJECT#1, I used what is arguably the most 
comprehensive health assessment database on the U.S. population, and found average daily 
minutes of moderate-to-vigorous physical activity was significantly associated with lower insulin 
resistance, but VO2max was not.  Although probing large data-sets, like NHANES, to address 
important questions and explore compelling relationships is interesting and impactful, there are 
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obviously several limitations associated with analysis of these large data sets (e.g., heterogeneous 
population, no control of the subjects activity and diet before testing, the outcome measures are 
greatly limited).  My findings in PROJECT#1 provided the impetus and foundation for PROJECT 
#2, in which I recruited a homogeneous population of overweight-to-mildly obese adults to be 
better able to strictly control their diet and physical activity, and this approach also enabled me to 
assess their cardiometabolic risk factors more comprehensibly.  In this study, I found that regular 
exercisers did exhibit higher insulin sensitivity compared with a well-matched cohort of non-
exercisers, even when the exerciser abstained from their regular exercise routine for 3 days, which 
was in contrast with my original hypothesis.  Because our group of regular exercisers in PROJECT 
#2 also had higher VO2max than the non-exercisers, I could not distinguish between the metabolic 
benefits due to the elevated VO2max compared with other adaptations stemming from exercising 
regularly.  Importantly, in PROJECT #3 significant improvements in both insulin sensitivity and 
blood cholesterol were found with 3-months of a mild-intensity exercise program without 
improving VO2max.  Together these studies support our working hypotheses that exercise induced 
improvements in health may be largely independent of specific physiologic adaptations 
responsible for improvedVO2max.   
 
The physiological consequences of obesity that lead to reduced cardiometabolic health are 
complex.  However, available evidence suggests that excessive abundance of fatty acids, 
accumulation of deleterious lipid species (i.e., DAG and ceramide) and increased pro-
inflammatory stress within skeletal muscle may be mediators of reduced health and in particular 
insulin sensitivity among obese adults.  Therefore, a working hypothesis of our laboratory is that 
exercise may improve insulin sensitivity in obese adults in part through altering the metabolic fate 
of fatty acids that enter the muscle cell, thereby reducing pro-inflammatory stress within skeletal 
muscle.  This hypothesis is largely based on previous findings from our laboratory by Dr. Schenk 
and Dr. Newsom who examined the effects of acute exercise on skeletal muscle lipid partitioning 
and pro-inflammatory stress.  For example, Dr. Schenk found that compared with remaining 
sedentary, a single session of vigorous exercise protected against lipid induced insulin resistance 
in lean adults.  Importantly this was accompanied by an increase in accumulation of neutral lipid 
stores (IMTG) and reduced accumulation of negative lipid species (i.e., DAG and ceramide) as 
well as skeletal muscle pro-inflammatory stress.  Additionally, Dr. Newsom found that a single 
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session of low-intensity exercise increased insulin sensitivity in obese adults with only modest 
changes in muscle lipid accumulation and no change in pro-inflammatory stress.  While these 
earlier projects focused exclusively on the important metabolic effects of acute exercise, the 
projects of my dissertation expanded on these findings by examining the effects of cumulative 
sessions of exercise and exercise training (in addition to acute exercise responses) on insulin 
sensitivity, skeletal muscle lipid-partitioning and pro-inflammatory stress.  My projects also extend 
on previous work in our lab by peering into the potential effects of exercise on adipose tissue 
inflammation and cytokine production.  Accumulating evidence suggests that adipose tissue and 
systemic pro-inflammatory stress contribute to insulin resistance among obese adults.  However, 
it is not clear that improvements in insulin sensitivity following exercise training are mediated by 
reductions in adipose tissue or systemic pro-inflammatory stress especially among weight stable 
overweight and obese adults.  In PROJECT #2, I found that increased insulin sensitivity following 
a single session of moderate intensity exercise was significantly associated with reductions in pro-
inflammatory cytokine IL-1.  Although we cannot assume a cause-and-effect relationship with 
these findings, these results support growing evidence indicating that exercise training induced 
reductions in systemic pro-inflammatory stress may contribute to exercise induced improvements 
in insulin sensitivity.  Conversely in PROJECT #3 neither an acute session of low-intensity 
exercise nor low-intensity exercise training relieved markers of adipose tissue, systemic, or 
skeletal muscle pro-inflammatory stress.  Additionally we did not see changes in accumulation of 
IMTG or DAG within skeletal muscle.  As noted above, it is possible that the exercise stimulus in 
PROJECT #3 may not have been sufficient to induce these changes.   
 
A better understanding of the cardiometabolic health benefits associated with acute and habitual 
exercise training has certainly been gained from the results of these dissertation projects.  However, 
questions still remain.  Due to the cross-sectional study design of PROJECT #1 we cannot 
determine causality between the inverse relationship in habitual physical activity level and insulin 
resistance.  It is possible that the persistent effect of regular exercise training on insulin sensitivity 
observed in PROJECT #2 was, at least in part, due to the physiologic adaptations associated with 
enhanced VO2max.  However in PROJECT #3, clinically relevant improvements in indices of 
insulin sensitivity and blood cholesterol were apparent after just two weeks and three months, 
respectively of a mild exercise training program that did not result in a significant increase in 
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VO2max.  Therefore, although significant improvements in key health outcome measures were 
observed with exercise training in the absence of improved VO2max, it cannot definitively be 
determined whether enhanced insulin sensitivity following exercise training is independent of 
physiologic adaptations leading to increased VO2max.  Finally although reductions in pro-
inflammatory cytokine IL-1 was associated with enhanced insulin sensitivity in PROJECT #2, it 
is not clear that this relationship is casual, and/or if other inflammatory markers and pathways may 
be impacted more profoundly by exercise and exercise training. 
 
In summary my dissertation projects support our current understanding that important 
improvements in metabolic health can be derived from a single session of exercise in 
overweight/obese adults given a “sufficient” exercise stimulus.  These studies also support the 
notion that exercise induced reductions in pro-inflammatory stress may be a key mediators in 
exercise induced improvements in insulin sensitivity.  Notably these studies assert the importance 
of regular exercise in combating the physiologic consequences of obesity.  Importantly I have 
shown that persistent improvements in insulin sensitivity and blood cholesterol can be derived 
from regular exercise in overweight/obese adults.  Finally, these studies confirm that clinically 
meaningful improvements in health can be achieved in the absence of increase in VO2max.  
Together, these findings can help inform the development of more effective exercise/lifestyle 
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Additional Analyses for PROJECT #1 (Chapter 3): 
Multiple linear regression analysis examining the independent associations of physical 
activity and cardiorespiratory fitness on some key cardiorespiratory disease risk factors 
In my dissertation proposal, I indicated that I would examine the independent associations of 
objectively measured physical activity and cardiorespiratory fitness on insulin sensitivity as well 
as other measures of metabolic and cardiovascular health (i.e., mean arterial pressure, plasma 
cholesterol, and c-reactive protein (CRP).  In Chapter 3 of my dissertation, I have provided the 
manuscript from this study that was very recently accepted for publication (5).  In the process of 
revising this manuscript for publication we were asked to simplify the scope of the project and 
only focus on the independent associations between physical activity and cardiorespiratory fitness 
and insulin sensitivity.  As a result, findings for the other outcome measures I proposed were not 
include in the manuscript (and do not appear in Chapter 3 of my dissertation).  I have included 
these data here.  
 
Methods summary 
Additional multiple linear regressions were performed with mean arterial pressure (Model 1), total 
cholesterol (Model 2), and log c-reactive protein (Model 3) as the dependent variable.  C-reactive 
protein was transformed using the log function to correct for the skewed distribution.  Minutes of 
MVPA and VO2max were the primary predictor variables. Appropriate confounding variables 
including: adiposity, sex, and age were also included in our complete model. 
 
Results 
The cohort of participants used for this analysis was identical to those used in Chapter 3 and 
participant characteristics were previously presented (Chapter 3, Table 3-1).  In our complete 
models for mean arterial pressure (MAP; Model 1), total cholesterol (Total-C; Model 2), and log 
c-reactive protein (log CRP; Model 3), that included predicting (cardiorespiratory fitness and 
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MVPA) confounding variables (body fat percentage, age and sex), neither cardiorespiratory fitness 
nor MVPA were significantly correlated with MAP, Total-C, or log CRP. Our analysis did not 
show any evidence of moderation when stratified by sex (data not shown). 
 
Discussion 
In this additional analysis we found that neither cardiorespiratory fitness nor MVPA were 
significantly associated with MAP, Total-C, or CRP.  These findings were in line with our 
observation in PROJECT #2 that blood pressure, blood lipids, and markers of systemic 
inflammation were similar between sedentary and regular exercising overweight but otherwise 
healthy (i.e., no signs of hypertension or dyslipidemia) adults.  Conversely in PROJECT #3 we 
found that adapting a mild exercise training program resulted in significant reductions in Total-C 
driven by a reduction in low-density lipoprotein cholesterol (LDL-C) among previously sedentary 
but obese adults.  Although participants in PROJECT #3 were also otherwise healthy they did 
show less than “ideal” LDL-C.  As previously discussed, reductions in markers of cardiometabolic 
disease risk following exercise training are typically quite modest in the absence of weight loss (3, 
4) but slightly more robust in individuals with additional increased risk due to diagnosed 
dyslipidemia and/or hypertension (1, 2).  Importantly this regression analysis was limited to 
healthy adults between the ages of 18-45 with no history of diabetes (or taking medication to treat 
diabetes), cardiovascular or renal disease, stroke or emphysema.  Therefore, in line with findings 
from PROJECT #2 and PROJECT #3 the fact that we did not detect a significant association 
between either of our predictor (e.g., cardiorespiratory fitness and MVPA) and outcome variables 
(e.g., MAP, Total-C, and CRP) may be reflective of cohort of healthy participants used in this 







Appendix 1 Table A. Linear regression models predicting mean arterial pressure, 









Physical Activity (30 min of MVPAa) -1.0395 4.4493 -0.1549 
(0.201) (0.292) (0.075) 
Estimated VO2 Maxb (ml/kg/min) -0.1099 -0.2438 -0.0063 
(0.142) (0.363) (0.499) 
Body Fat  (%) 0.1952 0.9230 0.0892 
(0.013) (0.046) (<0.001) 
Age (yrs.) 0.3465 1.2211 -0.0026 
(<0.001) (<0.001) (0.767) 
Sex Male = 1; Female = 0 -8.418 -10.1801 -0.6608 
(<0.001) (0.025) (0.001) 
Adjusted r 2 0.238 0.140 0.257 
For all models n=402.  a moderate-to-vigorous physical activity b maximal oxygen consumption 
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Physical Activity Questionnaire 
 
Subject ID:     Date:   Protocol:  
How often do you 
participate in the 
following activities? 
Exercise Frequncy during the week 
None 
Minutes Hours 
<15  15-30 30-45 45-60 1-1.5 2 to 3 4 to 6 7 to 10 More than 11 
Walking                     
Jogging                     
Running                     
Biking                     
Stationary Bike                     
Swimming                     
Tennis, raquetball                     
Basketball                     
Dancing                     
Rock Climbing                     
Hiking                     
Gymnastics                     
Gardening, house work                     
Skiing, skating                     
Martial arts                     
Weight Lifting                     
Football                     
Soccer                     
Aerobics                     
Rowing                     
Yoga, pilates                     
Eliptical                     
Other:                     





Skeletal muscle lipid analysis 
 
Skeletal Muscle Diacylglycerol and Triacylglycerol: Purification by Solid Phase Extraction, Thin 
Layer Chromatography, Gas Chromatography & Mass Spectrometry 
 
A. Preparation of Total Muscle Lipid Extract1 
 
1) Pre-weighed frozen muscle (~30 mg) rapidly homogenized in a ground-glass 
homogenizer (room temp) containing: 
a) 0.5 ml chlororform (CHCl3) + butylhydroxytoluene (BHT)2 (10 µg/ml) + internal 
lipid standards3 
b) 1.0 ml methanol (MeOH) 
c) 0.4 ml 0.9% NaCl (saline) 
 
2) Homogenate transferred to 16x125 mm extraction tube using a Pasteur pipet; save 
pipet 
 
3) Homogenizer rinsed twice with 1.9 ml volumes of the solvent mix [CHCl3 + BHT] + 
MeOH + saline (1:2:0.8); rinses added to extraction tube with saved pipet 
 
4) Capped tube vortexed gently 1.5h at room temp → lipids extracted into ~5.7 ml of a 
single phase solvent mix 
 
B. Isolation of the Lipid Phase 
  
1) After room temp incubation, the following added in this sequence (with vortexing): 
1st:  1.5 ml [CHCl3 + BHT] 
2nd: 1.5 ml saline 
 
Notes:  CHCl3 addition before saline improves yield
145 
 
CHCl3:MeOH:saline ratio changes to 1:1:0.9, forming a two-phase system 
with lipid-containing CHCl3 as the lower phase (3.0 ml) 
 
2) Tube centrifuged at ~2,300 x g for 10 min at room temp to sharpen interface 
 
3) Upper phase + precipitated protein at interface removed by aspiration 
 
4) Lipid phase transferred to clean tube and dried in speed-vac w/o heat 
 
Note: avoid excessive drying time; tube in moving rotor warms after solvent 
evaporates, even under partial vacuum and without heating the chamber 
 
C. Lipid Application to Bulk Silica  
 
1) 3.0 ml of 15% ethyl acetate (EtOAc) in hexane added to the lipid residue to dissolve 
diacylglycerol (DAG), triacylglycerol (TAG) and other lipids of progressively lower 
polarity; tube vortexed 30 sec 
 
Notes: monoacylglycerol (MAG) is minimally soluble in 15% EtOAc/hexane, 
and phospholipid (PL) is very poorly soluble 
some MAG and PL will remain bound to the glass surface of the tube 
 
2) Solution transferred to extraction tube containing 500 mg normal phase silica4; tube 
vortexed and dried 
 
D. Extraction and Removal of Cholesteryl Esters 
 
1) 5.0 ml of 0.25% EtOAc/hexane added and tube vortexed 2 min 
 
2) Tube centrifuged to compact silica; supernatant containing cholesteryl esters (CE) 
removed 
 




E. Extraction of an Enriched [DAG+TAG] Fraction 
 
1) Steps in section D again performed, except using 15% EtOAc/hexane to extract 
mainly DAG and TAG 
 
2) Supernatants (10 ml) combined, dried and stored at -20°C 
 
Note:  MAG and PL that transfer (see section C) are largely retained in the silica 
during this [DAG+TAG] extraction 
 
F. Purification of DAG and TAG by Thin Layer Chromatography (TLC)5 
 
1) Plate Preparation: 
a) 19-channel, normal phase TLC plates with preadsorbent sample streaking area6 
heated at 130°C for 30 min in GC oven to remove residual water vapor 
b) Plates cooled to room temp, then run in MeOH in TLC chamber until solvent 
front reaches top of plates 
c) Plates air-dried in fume hood and stored in an air-tight container with desiccant 
until sample application 
 
2) Sample Application: 
a) [DAG+TAG] residue reconstituted in 35 µl 15% EtOAc/hexane; the entire 
recoverable volume was streaked in a channel loading area 
b) Second  35 µl vol added to sample tube, and this streaked in a second channel 
adjacent to the first 
c) Mix of the internal standard lipids streaked in separate channels 
d) Streaks air-dried thoroughly by placing plate atop GC oven (warm surface) 
 
3) TLC Run: 
a) TLC chamber equilibrated with solvent mixture for 1h 
solvent mix = hexane + diethyl ether + glacial acetic acid (70:30:1) 
b) After chamber equilibration, solvent depth adjusted to ~3 mm 
c) Plates placed in chamber rack, and rack then inserted into chamber to start run 
d) TLC ended when solvent front reached 1.5 cm from plate tops by removing rack 
from chamber 
e) Plates thoroughly air-dried in fume hood, then carefully wrapped in aluminum foil 
and stored in a freezer bag at -20°C until lipid recovery step 
 
G. Lipid Recovery, Alkaline Methanolysis and GCMSD: done first with TLC channels 




1) Internal Lipid Standard Recovery: 
a) In a standard channel, fifteen 1 cm-silica segments collected above the loading 
area; upper 2.5 cm of the loading area (streak zone) also obtained; scraping done 
with a vacuum-assisted collection device 
b) Silica samples transferred to 16x100 mm extraction tubes and stored at -20°C 
 
2) Alkaline Methanolysis7 of Internal Standards: 
a) 1.0 ml 15% EtOAc/hexane added to silica; tube vortexed 30 sec and centrifuged; 
50 µl supernatant transferred to a 12x75 mm tube and dried 
b) 250 µl 0.6N sodium hydroxide (NaOH) in MeOH added to dried residue; tube 
vortexed and incubated at room temp for 30 min 
 
Note: during this incubation fatty acids convert from glyceryl or 
cholesteryl esters to methyl esters 
 
c) Reaction stopped by addition of 500 µl 1.0M sodium acetate (NaOAc) buffer, 
pH4.75 
d) FAMES extracted into 1 ml hexane; tube vortexed after hexane addition and then 
centrifuged; hexane w/FAMES (upper phase) transferred to clean tube and dried 
 
3) Gas Chromatography & Electron-Impact Mass Spectrometry8: 
a) FAME residue dissolved in 50 µl heptane and transferred to analyzer vial insert 
b) 1 or 2 µl injected into GCMS; selected ions monitored (typically ions 74, 79 and 
molecular) at retention times for individual FAMES 
c) Channel location and purity of DAG, TAG and other lipid standards determined 
 
4) Muscle DAG and TAG Recovery and Processing: 
a) Internal std-determined channel sections (~2.5 cm) for muscle DAG or TAG 
collected as above; same sections pooled from the two channels used per sample 
b) Alkaline methanolysis performed as above, except the entire DAG sample used; 
0.25 ml (from 1 ml) of the TAG sample used 
c) GCMSD as above 
 
H. Basic Calculations 
 
1) FAME ion peak area values corrected for background using assay blanks: 
a) Blank 1 = w/o muscle, w/ internal stds → for endogenous FA corrections 




2) Conversion of ion peak areas  to “picomoles injected” for each FA species measured, 
using individual FAME standard curves 
 
3) Conversion of “pmol FA injected” to “nmol lipid-derived FA / sample” by dividing 
the pmol value by the fractional recovery of the internal std-derived FAME 
(C15:0ME for DAG, C17:1ME for TAG), and then dividing by 1000 (pmol to nmol) 
 
4) Calculation of nmol DAG (or TAG) / mg muscle wet weight = summed nmol DAG 
(or TAG)-derived fatty acids / 2 (or 3) / mg wet wt 
 
5) Calculation of FA profile for DAG or TAG = nmol each FA / sum x 100 
 
Superscript 
1. Lipid extraction adapted from: 
a) Bligh EG and WJ Dyer.  A rapid method of total lipid extraction and purification.  
Can J Biochem Physiol 8: 911-917, 1959. (primary reference) 
b) Tepper AD and WJ Van Blitterswijk.  Ceramide mass analysis by normal-phase high-
performance liquid chromatography.  Methods Enzymol 312: 16-22, 2000. 
(secondary reference) 
 
2. BHT (Sigma) = 3,5-Di-tert-butyl-4-hydroxytoluene 
Acts as an anti-oxidant; protects  unsaturated lipids from oxidative rancidification 
 
3. Internal lipid standards added to homogenizer in 0.5 ml CHCl3: 
a) Cholesteryl tridecanoate (Nu-Chek) [C13:0]-CE  10.0 nmol 
b) Dipentadecanoin (Nu-Chek)  [C15:0]2-DAG 10.0 nmol 
c) Heptadecanoic acid (Nu-Chek)  [C17:0]-NEFA 20.0 nmol 
d) Triheptadecenoin (Nu-Chek)  [C17:1]3-TAG  16.0 nmol 
e) Monononadecanoin (Nu-Chek)  [C19:0]-MAG  12.0 nmol 
f) Dinonadecenoin (Nu-Chek)  [C19:1]2-DAG 20.0 nmol 
g) 1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids) 
[C21:0]2-PC  16.0 nmol 
h) Tritricosanoin (Nu-Chek)   [C23:0]3-TAG  2.0 nmol 
 




5. TLC adapted from: 
Kaluzny MA, Duncan LA, Merritt MV and DE Eppse.  Rapid separation of lipid classes 
in high yield and purity using bonded phase columns.  J Lipid Res 26: 135-140, 1985. 
 
6. Whatman Linear-K Preadsorbent TLC plate, 60A pore diameter 
 
7. Alkaline methanolysis adapted from: 
Bodennec J, Brichon G, Zwingelstein G and J Portoukalian.  Purification of sphingolipid 
classes by solid-phase extraction with aminopropyl and weak cation exchanger columns.  
Methods Enzymol 312: 101-114, 2000. 
 
8. GCMSD equipment and major method aspects: 
a) Agilent 6890A gas chromatograph w/autoanalyzer tray and injector tower 
b) Agilent 5973N mass spectrometer 
c) Restek FAMEWAX GC column, 30 meter, 0.25 mm ID, 0.25 µm film thickness, 
crossbonded polyethylene glycol film 
d) Helium carrier gas, 1.0 ml/min 
e) Pulsed splitless injection (generally 1 µl) 
f) Initial oven temp = 130°C, hold 1 min 
Ramp = 10°C/min 






Exercise adherence data 
 





















PA1 62.0% 100.0% 61.0% 95.8% 66.5% 12 
PA2 61.0% 100.0% 61.1% 100.0% 61.9% 12 
PA3 62.0% 91.7% 63.7% 77.8% 62.0% 12 
PA4 63.0% 83.3% 60.6% 90.5% 59.9% 14 
PA8 61.0% 108.3% 61.0% 98.5% 60.5% 11 
PA9 66.0% 100.0% 61.1% 93.6% 60.5% 13 
PA11 63.0% 100.0% 62.1% 94.4% 61.6% 12 
PA12 62.0% 100.0% 62.5% 87.8% 59.8% 14 
PA13 62.0% 108.3% 61.0% 86.8% 60.4% 13 
PA15 63.6% 100.0% 61.5%    
       
Average 62.6% 99.2% 61.5% 91.7% 61.5% 12.56 
SD 1.5% 7.3% 1.0% 6.9% 2.0% 1.01 
SE 0.5% 2.3% 0.3% 2.3% 0.7% 0.34 
 
 
 
 
